<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">8710219</journal-id><journal-id journal-id-type="pubmed-jr-id">1493</journal-id><journal-id journal-id-type="nlm-ta">AIDS</journal-id><journal-id journal-id-type="iso-abbrev">AIDS</journal-id><journal-title-group><journal-title>AIDS (London, England)</journal-title></journal-title-group><issn pub-type="ppub">0269-9370</issn><issn pub-type="epub">1473-5571</issn></journal-meta><article-meta><article-id pub-id-type="pmid">24983541</article-id><article-id pub-id-type="pmc">4678954</article-id><article-id pub-id-type="doi">10.1097/QAD.0000000000000108</article-id><article-id pub-id-type="manuscript">HHSPA724126</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Systematic Review of Interventions for Reducing HIV Risk Behaviors among People Living with HIV in the United States, 1988&#x02013;2012</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Crepaz</surname><given-names>Nicole</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Tungol</surname><given-names>Maria Luisa V.</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Higa</surname><given-names>Darrel H.</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Vosburgh</surname><given-names>H. Waverly</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Mullins</surname><given-names>Mary M.</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Barham</surname><given-names>Terrika</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>Adegbite</surname><given-names>Adebukola</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>DeLuca</surname><given-names>Julia B.</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Sipe</surname><given-names>Theresa Ann</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>White</surname><given-names>Christina M.</given-names></name><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name><surname>Baack</surname><given-names>Brittney N.</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name><surname>Lyles</surname><given-names>Cynthia M.</given-names></name><xref ref-type="aff" rid="A1">a</xref></contrib></contrib-group><aff id="A1"><label>a</label>Prevention Research Branch, Division of HIV/AIDS Prevention, The U.S. Centers for Disease Control and Prevention</aff><aff id="A2"><label>b</label>ICF International, Inc</aff><author-notes><corresp id="FN1">Correspondence to: Nicole Crepaz, PhD, The U.S. Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, Prevention Research Branch, 1600 Clifton Rd., Mailstop E-37, Atlanta, Georgia, 30333, USA, Phone: 1-404-639-6149, Fax: 1-404-639-1950, <email>ncrepaz@cdc.gov</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>22</day><month>9</month><year>2015</year></pub-date><pub-date pub-type="ppub"><day>13</day><month>3</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>15</day><month>12</month><year>2015</year></pub-date><volume>28</volume><issue>5</issue><fpage>633</fpage><lpage>656</lpage><!--elocation-id from pubmed: 10.1097/QAD.0000000000000108--><abstract><sec id="S1"><title>Objective</title><p id="P1">To conduct a systematic review to examine interventions for reducing HIV risk behaviors among people living with HIV (PLWH) in the United States.</p></sec><sec id="S2"><title>Methods</title><p id="P2">Systematic searches included electronic databases from 1988 to 2012, hand searches of journals, reference lists of articles, and HIV/AIDS Internet listservs. Each eligible study was evaluated against the established criteria on study design, implementation, analysis, and strength of findings to assess the risk of bias and intervention effects.</p></sec><sec id="S3"><title>Results</title><p id="P3">Forty-eight studies were evaluated. Fourteen studies (29%) with both low risk of bias and significant positive intervention effects in reducing HIV transmission risk behaviors were classified as evidence-based interventions (EBIs). Thirty-four studies were classified as non-EBIs due to high risk of bias or non-significant positive intervention effects. EBIs varied in delivery from brief prevention messages to intensive multi-session interventions. The key components of EBIs included addressing HIV risk reduction behaviors, motivation for behavioral change, misconception about HIV, and issues related to mental health, medication adherence, and HIV transmission risk behavior.</p></sec><sec id="S4"><title>Conclusion</title><p id="P4">Moving evidence-based prevention for PLWH into practice is an important step in making a greater impact on the HIV epidemic. Efficacious EBIs can serve as model programs for providers in healthcare and non-healthcare settings looking to implement evidence-based HIV prevention. Clinics and public health agencies at the state, local, and federal levels can use the results of this review as a resource when making decisions that meet the needs of PLWH to achieve the greatest impact on the HIV epidemic.</p></sec></abstract><kwd-group><kwd>HIV prevention</kwd><kwd>evidence based intervention</kwd><kwd>people living with HIV</kwd><kwd>risk reduction</kwd><kwd>systematic review</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S5"><title>INTRODUCTION</title><p id="P5">In the United States, it is estimated that 1,144,500 persons aged 13 and older were living with HIV at the end of 2010 [<xref rid="R1" ref-type="bibr">1</xref>] and there were an estimated 47,500 new HIV infections in 2010 [<xref rid="R2" ref-type="bibr">2</xref>]. People living with HIV (PLWH) are key partners in reducing the number of new HIV infections. Many PLWH reduce their risk behaviors after learning about their HIV-seropositive status [<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R4" ref-type="bibr">4</xref>]. However, adopting and maintaining safer behaviors can be challenging for some [<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R6" ref-type="bibr">6</xref>]. Providing prevention interventions that reduce the risk of HIV transmission or acquisition of other sexually transmitted diseases (STDs), in addition to HIV treatment and care for improving the health of PLWH, are critical components of the U.S. National HIV/AIDS Strategy (NHAS) [<xref rid="R7" ref-type="bibr">7</xref>]. Identifying evidence-based interventions (EBIs) to help PLWH protect themselves and uninfected partners is considered to be the high priority of NHAS.</p><p id="P6">Meta-analyses and systematic reviews [<xref rid="R8" ref-type="bibr">8</xref>&#x02013;<xref rid="R10" ref-type="bibr">10</xref>] show that behavioral interventions for PLWH significantly reduce sexual risk behaviors. These systematic reviews are useful for understanding the overall effect on reducing HIV risk behaviors among PLWH. However, these reviews typically do not critically assess the quality of evidence by closely examining study design, implementation, analysis, and findings of individual interventions. Several evidence-based review groups such as the Cochrane Collaboration [<xref rid="R11" ref-type="bibr">11</xref>] and the Agency for Healthcare Research and Quality (AHRQ)[<xref rid="R12" ref-type="bibr">12</xref>] have emphasized the importance of assessing the risk of bias of individual studies as part of assessing the body of evidence. A thorough assessment of the risk of bias and findings of individual interventions can identify rigorously designed and implemented programs that show significant effects. Prevention providers can then use these efficacious interventions within their own clinics or communities.</p><p id="P7">Since 1996, the U. S. Centers for Disease Control and Prevention&#x02019;s (CDC) HIV/AIDS Prevention Research Synthesis (PRS) project has been conducting an on-going systematic review to identify behavioral interventions with evidence of intervention efficacy [<xref rid="R13" ref-type="bibr">13</xref>]. Through multiple consultations with internal and external HIV prevention researchers and methodology experts, PRS developed the Risk-Reduction Efficacy criteria to assess various sources of bias in a study&#x02019;s design, implementation, analysis, and findings [<xref rid="R14" ref-type="bibr">14</xref>]. The PRS criteria are similar to the evaluation components used or recommended by other groups such as the Cochrane Collaboration [<xref rid="R11" ref-type="bibr">11</xref>], AHRQ [<xref rid="R12" ref-type="bibr">12</xref>], Community Guide [<xref rid="R15" ref-type="bibr">15</xref>], Office of Adolescent Health [<xref rid="R16" ref-type="bibr">16</xref>], Office of Justice&#x02019;s Crime Solutions [<xref rid="R17" ref-type="bibr">17</xref>], and Grades of Recommendation Assessment, Development and Evaluation (GRADE) [<xref rid="R18" ref-type="bibr">18</xref>]. To ensure a reasonable level of confidence that the observed changes can be attributed to the intervention [<xref rid="R13" ref-type="bibr">13</xref>], interventions that meet all the study design, implementation and analysis criteria are considered low risk of bias while interventions that do not meet all of these criteria are considered high risk of bias. Interventions with low risk of bias that show significant positive intervention effects on reducing HIV risk behaviors are defined as evidence-based interventions (EBIs) and the interventions with high risk in bias, regardless of intervention effects, are defined as non-EBIs. The EBI classification approach is consistent with other systematic review efforts (e.g., Office of Adolescent Health [<xref rid="R16" ref-type="bibr">16</xref>], National Registry of Evidence-Based Programs and Practices [<xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R20" ref-type="bibr">20</xref>], Office of Justice&#x02019;s Crime Solutions [<xref rid="R17" ref-type="bibr">17</xref>]) in identifying evidence-based programs and interventions.</p><p id="P8">In this systematic review, we reviewed all U.S.-based HIV risk reduction studies for PLWH available in the literature. Our goals were to describe the characteristics of the studies and interventions and to compare the similarities and differences between EBIs and non-EBIs. More specifically, we compared EBIs against two groups of non-EBIs: rigorous non-EBIs (i.e., interventions with low risk of bias but without significant positive intervention effects) and positive non-EBIs (i.e., interventions with high risk of bias but with significant positive intervention effects). These comparisons can provide helpful guidance for identifying research gaps, informing intervention development, and guiding prevention efforts.</p></sec><sec sec-type="methods" id="S6"><title>METHODS</title><p id="P9">We used the CDC&#x02019;s PRS project&#x02019;s cumulative HIV/AIDS/STD prevention database [<xref rid="R21" ref-type="bibr">21</xref>] for identifying relevant reports (see eligibility criteria below). For the PRS database, M.M.M. and J.D. with substantial expertise in systematic searches developed and conducted a comprehensive search strategy, including automated and manual searches. The annual automated search component focused on literature published between 1988 and 2012 using the following electronic databases (and platforms): EMBASE (OVID)[<xref rid="R22" ref-type="bibr">22</xref>], MEDLINE (OVID)[<xref rid="R23" ref-type="bibr">23</xref>], PsycINFO (OVID)[<xref rid="R24" ref-type="bibr">24</xref>], and Sociological Abstracts (PROQUEST)[<xref rid="R25" ref-type="bibr">25</xref>]. For the automated search, indexing and keywords terms were cross-referenced using Boolean logic in three areas: HIV/AIDS; prevention and intervention evaluation; and behavioral or biologic outcomes related to HIV infection or transmission (e.g., unprotected sex, condom use, needle sharing, STD. No language restriction was applied to the automated search. The last automated search was conducted in January, 2013. The full search strategy of the MEDLINE database is provided in <xref rid="SD1" ref-type="supplementary-material">Appendix A</xref> as an example. The searches of the other databases are available from the corresponding author. The manual search included three components: (a) searches of all reports published in the previous 3 months of 36 journals (see <xref rid="SD2" ref-type="supplementary-material">Appendix B</xref>) to identify potentially relevant citations not yet indexed in electronic databases. The last quarterly search was conducted in January, 2013; (b) the reference lists of pertinent articles; and (c) HIV/AIDS Internet listservs (i.e., <ext-link ext-link-type="uri" xlink:href="www.RobertMalow.org">www.RobertMalow.org</ext-link>) and other research databases (e.g., ISI Web of Knowledge [<xref rid="R26" ref-type="bibr">26</xref>], RePORTER [<xref rid="R27" ref-type="bibr">27</xref>], Cochrane Library [<xref rid="R28" ref-type="bibr">28</xref>]).</p><p id="P10">Studies were included for this review if they were: (1) interventions to reduce HIV risk behavior; (2) specifically designed for PLWH; (3) conducted in the U.S.; (4) tested in controlled trials with a comparison arm; (5) measured HIV behavioral or biological outcomes (e.g., condom use, unprotected sex, number of sex partners, needle sharing, STD); (6) and published between January 1988 and December 2012. We excluded pilot studies if the full-scale efficacy trials were eligible. Linked citations, defined as publications offering additional information on the same study, were included if they provided relevant intervention evaluation information.</p><p id="P11">Pairs of trained coders independently coded each eligible intervention against the established PRS Risk-Reduction Efficacy criteria which are publically available at <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/hiv/dhap/prb/prs/efficacy/rr/criteria/index.html">http://www.cdc.gov/hiv/dhap/prb/prs/efficacy/rr/criteria/index.html</ext-link> [<xref rid="R14" ref-type="bibr">14</xref>]. If a study did not report critical information needed to determine intervention efficacy, we contacted the primary study investigator to obtain missing information or clarification. The final efficacy determination for each study was reached by PRS team consensus.</p><p id="P12">Additionally, each eligible study was coded using a standardized coding form for the following: study characteristics (e.g., study date, location, study design, sample size, data collection method), participant characteristics (e.g., target population, gender, race/ethnicity, sexual orientation), intervention characteristics (e.g., components, delivery method, duration, time span) and HIV risk outcomes (e.g., HIV transmission risk behavior [TRB] defined as unprotected sex with HIV-negative or serostatus unknown partners or sharing needles with HIV-negative or serostatus unknown partners, unprotected sex or condom use with any sex partners, injecting drugs, needle sharing, STD).</p><p id="P13">Eligible studies were classified into four groups based on the risk of bias and evidence of intervention effects:</p><list list-type="bullet" id="L1"><list-item><p id="P14">EBIs: Low risk of bias with statistically significant positive intervention effects on at least one relevant HIV risk outcome</p></list-item><list-item><p id="P15">Rigorous non-EBIs: Low risk of bias without significant positive intervention effects</p></list-item><list-item><p id="P16">Positive non- EBIs: High risk of bias with statistically significant positive intervention effects on at least one relevant HIV risk outcome</p></list-item><list-item><p id="P17">Other non-EBIs: High risk of bias without significant positive intervention effects</p></list-item></list><p id="P18">For each of the two a-priori comparisons (i.e., EBIs vs. Rigorous non-EBIs and EBIs vs. Positive non-EBIs), we conducted Fisher&#x02019;s exact tests using SPSS version 21. In the results section, we highlighted the findings if the differences between groups reached p&#x0003c;.05, two-sided, on Fisher&#x02019;s exact tests or if the p value approached 0.10 or percentage differences between the groups were 20% or more.</p></sec><sec sec-type="results" id="S7"><title>RESULTS</title><p id="P19">As of December 2012, PRS evaluated 405 U.S.-based risk-reduction interventions that were evaluated with a comparison group (<xref rid="F1" ref-type="fig">Figure 1</xref>). Although PLWH comprise an important group in the HIV prevention effort, only 49 of 405 (12%) HIV prevention studies conducted in the United States met inclusion criteria and were specifically designed for this group. One pilot study [<xref rid="R29" ref-type="bibr">29</xref>] was excluded as the full-scale efficacy trial [<xref rid="R30" ref-type="bibr">30</xref>] was later published.</p><sec id="S8" sec-type="intro"><title>Overall Characteristics of Interventions for PLWH in the United States</title><p id="P20"><xref rid="T1" ref-type="table">Table 1</xref> provides brief descriptive characteristics of the 48 included interventions [<xref rid="R30" ref-type="bibr">30</xref>&#x02013;<xref rid="R77" ref-type="bibr">77</xref>] and <xref rid="T2" ref-type="table">Table 2</xref> provides a summary of the characteristics across interventions. Among 48 studies, the majority of the studies were conducted in earlier HAART era (1996 to 2003) and later HAART era (2004 to 2012). Forty-three studies (90%) were randomized control trials (RCT). Regionally, most interventions were carried out in the West, followed by the Northeast and South. The fewest interventions were conducted in the Midwest. Not surprisingly, most of the studies were conducted in urban settings, such as Atlanta, Baltimore, Boston, Chicago, Houston, Los Angeles, Miami, Milwaukee, New York City, Philadelphia, San Francisco, and Washington DC, except one study that was conducted by phone in rural areas of 27 states.</p><p id="P21">The most commonly targeted groups were clinic patients [<xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R37" ref-type="bibr">37</xref>&#x02013;<xref rid="R40" ref-type="bibr">40</xref>, <xref rid="R43" ref-type="bibr">43</xref>, <xref rid="R48" ref-type="bibr">48</xref>, <xref rid="R54" ref-type="bibr">54</xref>, <xref rid="R59" ref-type="bibr">59</xref>, <xref rid="R60" ref-type="bibr">60</xref>, <xref rid="R62" ref-type="bibr">62</xref>, <xref rid="R64" ref-type="bibr">64</xref>, <xref rid="R65" ref-type="bibr">65</xref>, <xref rid="R68" ref-type="bibr">68</xref>&#x02013;<xref rid="R70" ref-type="bibr">70</xref>, <xref rid="R74" ref-type="bibr">74</xref>], followed by men who have sex with men (MSM) [<xref rid="R33" ref-type="bibr">33</xref>, <xref rid="R34" ref-type="bibr">34</xref>, <xref rid="R47" ref-type="bibr">47</xref>, <xref rid="R52" ref-type="bibr">52</xref>, <xref rid="R54" ref-type="bibr">54</xref>, <xref rid="R61" ref-type="bibr">61</xref>, <xref rid="R64" ref-type="bibr">64</xref>&#x02013;<xref rid="R66" ref-type="bibr">66</xref>, <xref rid="R68" ref-type="bibr">68</xref>, <xref rid="R71" ref-type="bibr">71</xref>, <xref rid="R72" ref-type="bibr">72</xref>, <xref rid="R75" ref-type="bibr">75</xref>] and PLWH who engaged in TRB [<xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R35" ref-type="bibr">35</xref>, <xref rid="R36" ref-type="bibr">36</xref>, <xref rid="R49" ref-type="bibr">49</xref>, <xref rid="R52" ref-type="bibr">52</xref>, <xref rid="R56" ref-type="bibr">56</xref>, <xref rid="R60" ref-type="bibr">60</xref>, <xref rid="R61" ref-type="bibr">61</xref>, <xref rid="R64" ref-type="bibr">64</xref>, <xref rid="R65" ref-type="bibr">65</xref>, <xref rid="R75" ref-type="bibr">75</xref>]. Another frequently targeted group was substance-abusing PLWH, including injection drug users [<xref rid="R50" ref-type="bibr">50</xref>, <xref rid="R53" ref-type="bibr">53</xref>, <xref rid="R58" ref-type="bibr">58</xref>], general drug users [<xref rid="R51" ref-type="bibr">51</xref>, <xref rid="R63" ref-type="bibr">63</xref>, <xref rid="R69" ref-type="bibr">69</xref>], substance-using MSM [<xref rid="R52" ref-type="bibr">52</xref>, <xref rid="R71" ref-type="bibr">71</xref>], methamphetamine users [<xref rid="R52" ref-type="bibr">52</xref>], cocaine users [<xref rid="R57" ref-type="bibr">57</xref>], crack users [<xref rid="R73" ref-type="bibr">73</xref>], and alcohol abusers [<xref rid="R71" ref-type="bibr">71</xref>]. Fewer studies specifically targeted the following subgroups of PLWH: women [<xref rid="R38" ref-type="bibr">38</xref>, <xref rid="R42" ref-type="bibr">42</xref>, <xref rid="R70" ref-type="bibr">70</xref>, <xref rid="R74" ref-type="bibr">74</xref>, <xref rid="R77" ref-type="bibr">77</xref>], African Americans [<xref rid="R34" ref-type="bibr">34</xref>, <xref rid="R36" ref-type="bibr">36</xref>, <xref rid="R72" ref-type="bibr">72</xref>, <xref rid="R73" ref-type="bibr">73</xref>], persons with depression or a history of childhood abuse [<xref rid="R46" ref-type="bibr">46</xref>, <xref rid="R67" ref-type="bibr">67</xref>, <xref rid="R77" ref-type="bibr">77</xref>], younger age groups (13 to 29 years) [<xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R62" ref-type="bibr">62</xref>, <xref rid="R63" ref-type="bibr">63</xref>], older adults (45 years and older) [<xref rid="R34" ref-type="bibr">34</xref>, <xref rid="R43" ref-type="bibr">43</xref>, <xref rid="R49" ref-type="bibr">49</xref>], newly HIV-diagnosed persons [<xref rid="R32" ref-type="bibr">32</xref>, <xref rid="R55" ref-type="bibr">55</xref>, <xref rid="R68" ref-type="bibr">68</xref>], male prison inmates [<xref rid="R41" ref-type="bibr">41</xref>], and persons who were homeless or at risk of homelessness [<xref rid="R76" ref-type="bibr">76</xref>].</p><p id="P22">The majority of the studies (88%) reported the theoretical principles used in designing the interventions. The most commonly used theories included: Social Cognitive Theory [<xref rid="R78" ref-type="bibr">78</xref>], Information Motivation and Behavioral Skills (IMB) model [<xref rid="R79" ref-type="bibr">79</xref>, <xref rid="R80" ref-type="bibr">80</xref>], Theory of Reasoned Action, Social Action Theory [<xref rid="R81" ref-type="bibr">81</xref>], Motivational Interviewing [<xref rid="R82" ref-type="bibr">82</xref>], Transtheoretical Model of Stage of Change [<xref rid="R83" ref-type="bibr">83</xref>], and Theory of Gender and Power [<xref rid="R84" ref-type="bibr">84</xref>]. Half of the interventions were conducted in healthcare settings, such as HIV outpatient clinics, community health centers, hospitals, or methadone treatment clinics. More than half of the interventions were delivered by professionals such as healthcare providers (19%), counselors or health educators (40%). Some were delivered by peers (27%). Two were computer-delivered interventions using interactive video doctors [<xref rid="R39" ref-type="bibr">39</xref>, <xref rid="R48" ref-type="bibr">48</xref>]. The majority of the interventions consisted of 3 to 10 sessions (63%) and lasted 1 to 3 months (69%). The median time per session was 90 minutes, ranging from 3&#x02013;5 minutes to 3 hours.</p><p id="P23">The most commonly reported outcomes (see <xref rid="T3" ref-type="table">Table 3</xref>) were TRB (21 studies) and unprotected sex behavior (partner serostatus not reported, 33 studies). About half of the studies that reported these two outcomes showed significant positive intervention effects (12 studies and 16 studies, respectively). There were fewer studies that reported injection drug use or needle sharing behaviors (5 studies). Additional three studies combined with sex and drug behaviors in a risk index. About half of these studies showed significant positive intervention effects. All the sex and drug use behaviors were based on self-report. Regarding biologic outcomes, only one study out of six studies that measured STD (lab confirmed or doctor&#x02019;s diagnosis) showed a significant positive intervention effect.</p></sec><sec id="S9"><title>Classification of EBIs and Non-EBIs Based on the Risk of Bias and Significant Positive Intervention Effects</title><p id="P24">Of the 48 included studies, 24 interventions (50%) had low risk of bias. Among these, 14 were EBIs that also showed significant positive intervention effects [<xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R36" ref-type="bibr">36</xref>, <xref rid="R37" ref-type="bibr">37</xref>, <xref rid="R39" ref-type="bibr">39</xref>, <xref rid="R40" ref-type="bibr">40</xref>, <xref rid="R44" ref-type="bibr">44</xref>, <xref rid="R45" ref-type="bibr">45</xref>, <xref rid="R54" ref-type="bibr">54</xref>, <xref rid="R59" ref-type="bibr">59</xref>, <xref rid="R62" ref-type="bibr">62</xref>, <xref rid="R63" ref-type="bibr">63</xref>, <xref rid="R67" ref-type="bibr">67</xref>, <xref rid="R74" ref-type="bibr">74</xref>, <xref rid="R75" ref-type="bibr">75</xref>] and the other 10 interventions were Rigorous non-EBIs [<xref rid="R42" ref-type="bibr">42</xref>, <xref rid="R43" ref-type="bibr">43</xref>, <xref rid="R55" ref-type="bibr">55</xref>, <xref rid="R58" ref-type="bibr">58</xref>, <xref rid="R61" ref-type="bibr">61</xref>, <xref rid="R64" ref-type="bibr">64</xref>, <xref rid="R69" ref-type="bibr">69</xref>, <xref rid="R71" ref-type="bibr">71</xref>, <xref rid="R73" ref-type="bibr">73</xref>, <xref rid="R76" ref-type="bibr">76</xref>]. Twenty-four interventions had high risk of bias, including 13 Positive non-EBIs [<xref rid="R30" ref-type="bibr">30</xref>, <xref rid="R33" ref-type="bibr">33</xref>, <xref rid="R35" ref-type="bibr">35</xref>, <xref rid="R41" ref-type="bibr">41</xref>, <xref rid="R48" ref-type="bibr">48</xref>&#x02013;<xref rid="R50" ref-type="bibr">50</xref>, <xref rid="R52" ref-type="bibr">52</xref>, <xref rid="R53" ref-type="bibr">53</xref>, <xref rid="R57" ref-type="bibr">57</xref>, <xref rid="R60" ref-type="bibr">60</xref>, <xref rid="R70" ref-type="bibr">70</xref>, <xref rid="R77" ref-type="bibr">77</xref>] and 11 Other non-EBIs [<xref rid="R32" ref-type="bibr">32</xref>, <xref rid="R34" ref-type="bibr">34</xref>, <xref rid="R38" ref-type="bibr">38</xref>, <xref rid="R46" ref-type="bibr">46</xref>, <xref rid="R47" ref-type="bibr">47</xref>, <xref rid="R51" ref-type="bibr">51</xref>, <xref rid="R56" ref-type="bibr">56</xref>, <xref rid="R65" ref-type="bibr">65</xref>, <xref rid="R66" ref-type="bibr">66</xref>, <xref rid="R68" ref-type="bibr">68</xref>, <xref rid="R72" ref-type="bibr">72</xref>]. Eighteen Positive and Other non-EBIs (75%) had multiple sources of bias. The common sources of bias included: analytic sample sizes less than 40 per arm, less than a 60% retention rate of study participants per arm, greater than 10% differential attrition between arms, substantial missing data, not conducting intent-to-treat analysis, or significant negative findings. Another way of looking at the breakdown of 34 non-EBIs is that 21 interventions (61%) did not find any significant positive intervention effects.</p></sec><sec id="S10"><title>Comparisons between EBIs and Rigorous Non-EBIs</title><p id="P25"><xref rid="T2" ref-type="table">Table 2</xref> and <xref rid="T3" ref-type="table">Table 3</xref> show comparisons between EBIs and rigorous non-EBIs. The two groups were similar in terms of target populations (i.e., MSM, those who engaged in HIV transmission risk), sample characteristics (i.e., race/ethnicity, gender, age), reporting of power analysis and theories, use of ACASI for data collection, several intervention components (i.e., self-efficacy, skills building, serostatus disclosure, social support, personalized risk reduction plan, personal responsibility, normative influence, intimate partner violence), and type of outcomes reported (e.g., TRB, unprotected sex behavior, injection drug use or needle sharing).</p><p id="P26">Despite the similarities, EBIs and Rigorous non-EBIs differed in a few ways. More EBIs than Rigorous non-EBIs were evaluated in the earlier HAART era (1996&#x02013;2003), carried out at multiple study locations, targeted clinic patients, delivered to individuals, conducted in healthcare settings, used standard of care or non-HIV attention controls (defined as receiving non-HIV intervention such as general health promotion that matched length and doses of HIV-intervention) as comparison groups. There was a higher percentage of EBIs than non-EBIs that addressed the following intervention components: discussing HIV risk-reduction, promoting motivation for behavioral change, addressing misperception about HIV, reducing negative affect such as depression or anxiety, enhancing medication adherence, and conducting risk screening to guide prevention messages. In contrast, more Rigorous non-EBIs were conducted in the later-ART era, targeted substance users, used HIV demand controls as comparisons (defined as participants in the comparison group are aware of the intervention they received were intended to change their sex or drug use risk), and had 3 to 12 intervention sessions over a period of 1 to 3 months</p></sec><sec id="S11"><title>Comparison between EBIs and Positive Non-EBIs</title><p id="P27">There were several similarities between EBIs and Positive non-EBIs. Comparable percentages of EBIs and positive non-EBIs were observed on the following: intervention level (i.e., individual, group, couple), intervention intensity and time span, and some intervention components (e.g., building skills and self-efficacy, conducting risk screening to guide personalized prevention messages, working with participants on personalized risk-reduction plans, emphasizing personal responsibility to take care of one&#x02019;s and partner&#x02019;s health, and addressing medication adherence issues). However, Positive non-EBIs were more likely to be small-scale studies conducted with subgroups of PLWH (e.g., rural areas, depressed MSM, meth-using MSM, injection drug users, substance users, women) compared to EBIs. Positive non-EBIs were less often conducted as multi-site studies and in health care settings or community-based establishments in contrast to EBIs. Positive non-EBIs were also less likely than EBIs to use non-HIV attention controls, use ACASI for data collection, report theories, and report and show positive intervention effects on TRB.</p></sec><sec id="S12"><title>Highlights of EBIs</title><p id="P28">While the comparisons between EBIs and two non-EBIs groups (i.e., Rigorous and Positive) can inform research gaps and future intervention development, a closer examination of the EBIs can provide helpful direction for providers in healthcare and non-healthcare settings in selecting model programs suitable for their target populations. More than half of EBIs targeted HIV clinic patients [<xref rid="R37" ref-type="bibr">37</xref>, <xref rid="R39" ref-type="bibr">39</xref>, <xref rid="R40" ref-type="bibr">40</xref>, <xref rid="R54" ref-type="bibr">54</xref>, <xref rid="R59" ref-type="bibr">59</xref>, <xref rid="R62" ref-type="bibr">62</xref>, <xref rid="R74" ref-type="bibr">74</xref>], but none targeted newly diagnosed PLWH. Six EBIs targeted specific subgroups of PLWH: MSM [<xref rid="R54" ref-type="bibr">54</xref>, <xref rid="R75" ref-type="bibr">75</xref>], heterosexual African American discordant couples [<xref rid="R36" ref-type="bibr">36</xref>], substance using youth and young adults [<xref rid="R63" ref-type="bibr">63</xref>], women [<xref rid="R74" ref-type="bibr">74</xref>], and PLWH with a history of childhood sexual abuse [<xref rid="R67" ref-type="bibr">67</xref>]. All 14 EBIs had greater than 50% ethnic minority participants (range: 53% to 100%), seven of which included a majority of African Americans. The key components of EBIs included addressing HIV risk reduction behaviors, motivation for behavioral change, misconception about HIV, and issues related to mental health, medication adherence, and HIV transmission risk behavior.</p><p id="P29">A variety of intervention delivery methods, ranging from brief prevention messages delivered during regular HIV care visits to intensive multi-session interventions over several weeks or months, were shown to be successful in reducing TRB as well as unprotected sex with any sex partners. Three EBIs were brief interventions. In one intervention, the healthcare provider delivered 3- to 5-minute prevention messages that focused on self-protection, partner protection, and disclosure. Posters and patient education brochures in the clinics reinforced provider-delivered prevention messages [<xref rid="R59" ref-type="bibr">59</xref>]. Another intervention used clinicians to deliver the 5- to 10-minute tailored prevention message based on risk screening information that patients provided [<xref rid="R37" ref-type="bibr">37</xref>]. In the third intervention, patients completed a computer-based risk assessment and then viewed a 24-minute video clip in which an actor-portrayed physician delivered risk-reduction messages tailored to the patient&#x02019;s unique risks. At the conclusion of the video section, patients received an educational worksheet for self-reflection, harm reduction tips, and local resources and clinicians received a cueing sheet that summarized patient&#x02019;s risk profile and suggested counseling statements [<xref rid="R39" ref-type="bibr">39</xref>].</p><p id="P30">Intensive behavioral risk-reduction interventions (defined as multiple sessions over weeks and months with a median of 90 minutes per session) in healthcare [<xref rid="R40" ref-type="bibr">40</xref>, <xref rid="R54" ref-type="bibr">54</xref>, <xref rid="R62" ref-type="bibr">62</xref>, <xref rid="R74" ref-type="bibr">74</xref>] and non-healthcare settings [<xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R36" ref-type="bibr">36</xref>, <xref rid="R44" ref-type="bibr">44</xref>, <xref rid="R45" ref-type="bibr">45</xref>, <xref rid="R63" ref-type="bibr">63</xref>, <xref rid="R67" ref-type="bibr">67</xref>, <xref rid="R75" ref-type="bibr">75</xref>] can also lead to reductions in risky sexual behaviors among PLWH. In 11 EBIs, peer-educators [<xref rid="R44" ref-type="bibr">44</xref>, <xref rid="R54" ref-type="bibr">54</xref>, <xref rid="R74" ref-type="bibr">74</xref>, <xref rid="R75" ref-type="bibr">75</xref>] or health educators/counselors [<xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R36" ref-type="bibr">36</xref>, <xref rid="R40" ref-type="bibr">40</xref>, <xref rid="R45" ref-type="bibr">45</xref>, <xref rid="R62" ref-type="bibr">62</xref>, <xref rid="R63" ref-type="bibr">63</xref>, <xref rid="R67" ref-type="bibr">67</xref>] provided multi-session interventions to individual PLWH [<xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R40" ref-type="bibr">40</xref>, <xref rid="R54" ref-type="bibr">54</xref>, <xref rid="R63" ref-type="bibr">63</xref>], small groups of adult PLWH [<xref rid="R44" ref-type="bibr">44</xref>, <xref rid="R45" ref-type="bibr">45</xref>, <xref rid="R62" ref-type="bibr">62</xref>, <xref rid="R67" ref-type="bibr">67</xref>, <xref rid="R74" ref-type="bibr">74</xref>, <xref rid="R75" ref-type="bibr">75</xref>], or discordant couples with HIV [<xref rid="R36" ref-type="bibr">36</xref>] with varied demographic characteristics. Interactive sessions focused on many topics such as coping with an HIV diagnosis, addressing serostatus disclosure, building condom use skills, negotiating safe sex behaviors, avoiding risky drug use, or medication adherence. Participants of all 11 EBIs were significantly less likely to report TRB or unprotected sex with any partners at some point within 3 to 12 months after interventions.</p></sec></sec><sec sec-type="discussion" id="S13"><title>DISCUSSION</title><p id="P31">Given the importance of reducing risk behaviors among PLWH for preventing new HIV infection and STDs, it is encouraging to have identified 14 EBIs that had low risk of bias and showed significant positive intervention effects on reducing HIV risk behavior, especially for reducing TRB. These interventions can serve as model programs for providers in healthcare and non-healthcare settings seeking EBIs best suited for their target populations.</p><sec id="S14"><title>Brief Interventions in Healthcare Settings</title><p id="P32">The healthcare setting affords a great opportunity to integrate behavioral prevention with routine medical care and address behavior change over time. Consistent with a previous meta-analysis [<xref rid="R8" ref-type="bibr">8</xref>], we found two EBIs that showed brief prevention counseling messages (e.g., 3 to 10 minutes) delivered by healthcare providers during routine HIV care visits can lead to significant reductions in HIV transmission risk among PLWH. This brief provider-delivered risk-reduction approach has been implemented and evaluated in two large-scale demonstration projects [<xref rid="R86" ref-type="bibr">86</xref>, <xref rid="R87" ref-type="bibr">87</xref>]. Both studies showed the feasibility of conducting brief provider-delivered risk-reduction interventions in busy healthcare settings and the effectiveness of this approach in reducing HIV transmission risk behaviors of PLWH. Based on the body of evidence, the brief provider-delivered risk-reduction intervention during HIV patient&#x02019;s routine care visits has been recommended and currently promoted to be standard of HIV clinic care by CDC (i.e., Prevention IS Care [<xref rid="R88" ref-type="bibr">88</xref>]).</p><p id="P33">The importance of clinic provider&#x02019;s role in facilitating healthier behaviors of patients is not new. However, evidence suggests that providers are not consistently talking to patients about safer sex, injection drug use, and HIV prevention methods. Approximately 23% to 29% of HIV patients reported that their providers have never talked to them about safer sex [<xref rid="R89" ref-type="bibr">89</xref>, <xref rid="R90" ref-type="bibr">90</xref>]. The data on provider-patient communication in the most recent HIV primary care visit showed that 65% of HIV-seropositive injection drug users reported having discussed HIV prevention with their provider [<xref rid="R91" ref-type="bibr">91</xref>] and 53% of Ryan White CARE Act patients from 9 states reported having discussed safer sex and HIV prevention methods with their providers [<xref rid="R92" ref-type="bibr">92</xref>]. These percentages are similar to the percentages reported by healthcare providers [<xref rid="R93" ref-type="bibr">93</xref>]. Studies also showed that providers were more likely to provide prevention counseling to new patients rather than established patients [<xref rid="R93" ref-type="bibr">93</xref>, <xref rid="R94" ref-type="bibr">94</xref>]. These findings highlight considerable room to increase the delivery of brief prevention counseling by providers during routine HIV care visits, especially among returning patients.</p><p id="P34">Published studies in the literature indicate several common barriers to providing risk screening and risk reduction interventions in healthcare setting, including lack of time, competing priorities, limited staffing, providers&#x02019; lack of risk-reduction counseling skills, discomfort with talking about risk behaviors, and the belief that interventions will not change behavior [<xref rid="R92" ref-type="bibr">92</xref>, <xref rid="R93" ref-type="bibr">93</xref>, <xref rid="R95" ref-type="bibr">95</xref>&#x02013;<xref rid="R99" ref-type="bibr">99</xref>]. However, evidence suggests that training on brief risk screening methods requires minimal time and training on brief risk-reduction interventions enhances the provider&#x02019;s comfort, skill, efficiency, and motivation [<xref rid="R60" ref-type="bibr">60</xref>, <xref rid="R94" ref-type="bibr">94</xref>, <xref rid="R96" ref-type="bibr">96</xref>, <xref rid="R99" ref-type="bibr">99</xref>]. Providers are more likely to engage in risk-reduction prevention counseling if other providers in the same clinics are also providing prevention counseling. Additionally, providers who agree that risk-reduction prevention is part of the clinic&#x02019;s mission are more likely to conduct counseling to HIV patients [<xref rid="R94" ref-type="bibr">94</xref>]. Innovative approaches are needed to prepare and support providers for delivering more consistent risk-reduction interventions to their HIV patients. Some approaches to consider include integrating behavioral prevention into the clinic mission, providing training to enhance the provider&#x02019;s ability, motivation, and comfort to deliver brief preventions, reimbursing counseling time, and educating medical students about HIV prevention.</p></sec><sec id="S15"><title>More Intensive, Multi-session Interventions in Healthcare and Non-Healthcare Settings</title><p id="P35">Our systematic review also found that longer and multi-session HIV interventions are efficacious in changing HIV transmission risk behaviors of PLWH. The feasibility of delivering interventions with multiple sessions over time is not clear, especially in busy clinic facilities. However, these interventions are not without merit because some PLWH require additional help to address multiple interconnected factors (e.g., substance use, depression, childhood sexual abuse, interpersonal and partner dynamics) underlying their risk behaviors. Several intensive EBIs are successful in reducing risk behaviors among PLWH at high risk of transmitting HIV. Referrals for evidence-based, multi-session risk-reduction interventions for PLWH who report high levels of risk or continue risk behaviors may be a beneficial component of comprehensive HIV prevention efforts at the clinic/agency, state, and federal levels. Creating directories of local clinics or agencies that offer evidence-based, intensive risk-reduction interventions, facilitating the collaboration between clinic and community providers, and establishing policies and procedures regarding patient&#x02019;s referrals to intensive interventions can also be helpful to ensure the services are in place as needed [<xref rid="R100" ref-type="bibr">100</xref>].</p></sec><sec id="S16"><title>Considerations for Future PLWH Interventions</title><p id="P36">While our review identified several EBIs for healthcare and non-healthcare settings, the dissemination of the interventions remains limited as these settings often do not have the human or financial resources to devote to interventions. One potential solution is the use of new technologies. Computer-based interventions are shown to be efficacious in increasing condom use and reducing sexual activity, numbers of sexual partners, and incident STD [<xref rid="R101" ref-type="bibr">101</xref>]. The advantages include greater intervention fidelity, lower delivery costs, and greater flexibility in dissemination channels such as in person, by mail, on the webs, through cell phones [<xref rid="R101" ref-type="bibr">101</xref>]. Several computer-based interventions that address HIV risk behavior as well as mediation adherence and other issues (e.g., retention, treatment readiness) for PLWH are on the way (e.g., CDC and NIH funded comprehensive prevention with positive project, CDC funded computer-based Interactive Screening and Counseling Tool, CBISCT). More research is needed to explore the best way to incorporate new technologies to deliver HIV behavioral interventions that address the prevention needs of PLWH.</p><p id="P37">Several identified differences and similarities between EBIs and the two groups of non-EBIs (i.e., Rigorous and Positive) can inform the design and testing of future behavioral interventions for PLWH. EBIs tended to target HIV clinic patients whereas more of the two non-EBIs groups targeted specific high-risk populations (e.g., substance-using MSM, IDUs, substance abusers, sexual actively older adults, inmates, homeless) or understudied populations (e.g., rural residents, newly diagnosed).</p><p id="P38">When comparing EBIs and Rigorous non-EBIs, there were many more similarities than differences in study design, implementation and analysis, outcome measures, and intervention components. One unique difference is that EBIs were more likely to use standard of care or non-HIV attention control and less likely to use HIV demand controls. For HIV-related comparison groups, using variations of the interventions as comparison groups may greatly reduce the ability to detect intervention effects [<xref rid="R102" ref-type="bibr">102</xref>]. Using a standardized comparison arm that the HIV prevention field could agree upon as a prevention standard can facilitate comparing intervention effects across studies.</p><p id="P39">Unsurprisingly, when comparing EBIs and Positive non-EBIs, there were obvious differences in the sources of bias. More positive non-EBIs than EBIs were small sample size studies intended as pilot studies to test the feasibility of the intervention implementation. Several of non-EBIs also suffered from substantial attrition, differential retention, and missing data issues. While positive non-EBIs showed at least one significant positive finding on sex or injection drug use outcomes, few reported and found significant positive findings on TRB. Positive non-EBIs are good candidates for further evaluation and they should be evaluated with more rigorous methods that reduce the risk of bias in study design, implementation and analysis and that measure HIV transmission risk behavior.</p></sec><sec id="S17"><title>Limitations</title><p id="P40">The findings of our review must be viewed within the context of the limitations of the available evidence. First, although the majority of the studies were RCTs, many were un-blinded and relied on self-reported sexual behavior, which may open to social desirability bias [<xref rid="R103" ref-type="bibr">103</xref>]. Given that blinded trials are not feasible in HIV behavioral prevention research, future intervention trials should consider complementing self-reported behavioral measures with biologic outcomes such as STD to assess intervention efficacy [<xref rid="R104" ref-type="bibr">104</xref>]. There were very few studies in the current literature that measured both behavioral and biologic outcomes. Second, while the majority of EBIs demonstrated significant positive intervention effects on reducing unprotected sex with HIV-negative and serostatus unknown partners, it is unclear how the observed behavioral changes may translate into averted new infections. Many factors such as individual&#x02019;s viral load level, type of sex acts, and present of other STD may affect the probability of new HIV transmission. Although the complexity of the multiple influencing factors that could affect HIV transmission potential makes it impossible to estimate the number of new infections averted by the interventions reviewed here, our findings showed that some interventions are more successful than others in promoting positive behavior changes that are important factors in HIV transmission risk.</p><p id="P41">In addition, there are several limitations specific to this review that merit consideration when interpreting the findings. First, we classified all the U.S.-based interventions for PLWH into EBIs vs. non-EBIs based on the risk of bias and evidence of positive intervention effects. While this classification approach is intended to identify model programs, it differs from meta-analytic approaches, which provide the overall estimate of the intervention effects. Second, although we contacted primary investigators to confirm our evaluation of the risk of bias and intervention effects, the coding of study and intervention characteristics are based on published reports that may not provide complete information about the intervention. Third, our review relied on the published literature and our findings might be susceptible to for publication bias. Fourth, while we observed some patterns that may explain differences among EBIs and non-EBIs, there are multiple factors that may contribute to an intervention&#x02019;s lack of evidence and it is difficult to disentangle a specific reason or combination of reasons.</p></sec></sec><sec sec-type="conclusions" id="S18"><title>CONCLUSION</title><p id="P42">Despite these limitations, our findings also offer several implications for research and HIV prevention. Moving evidence-based prevention for PLWH into practice is an important step in making a greater impact on the HIV epidemic. Our systematic review identified several EBIs that can serve as model programs for providers in healthcare and non-healthcare settings who are looking to implement evidence-based interventions best suited for the populations they serve. The differences between EBIs and non-EBIs identified in this review point out that more EBIs are needed for the subgroups of PLWH such as substance-using MSM, injection drug users, sexually active older adults, inmates, homeless persons, rural residents and newly diagnosed persons. Healthcare settings where PLWH receive routine HIV medical care and other services continue to be an ideal setting to deliver behavioral interventions. Clinics and public health agencies at the state, local, and federal levels can use the results of this review as a resource when making decisions that meet the needs of PLWH to achieve the greatest impact on the HIV epidemic.</p></sec><sec sec-type="supplementary-material" id="S19"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>A</label><media xlink:href="NIHMS724126-supplement-A.doc" orientation="portrait" xlink:type="simple" id="d37e1109" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>B</label><media xlink:href="NIHMS724126-supplement-B.docx" orientation="portrait" xlink:type="simple" id="d37e1113" position="anchor"/></supplementary-material></sec></body><back><ack id="S20"><p>This work was supported by the Prevention Research Branch, Division of HIV/AIDS Prevention at the U.S. Centers for Disease Control and Prevention and was not funded by any other organization.</p></ack><fn-group><fn id="FN2"><p>The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention.</p></fn><fn id="FN3" fn-type="conflict"><p><bold>Conflicts of Interest</bold></p><p>All the authors declare no conflict of interest.</p></fn><fn id="FN4" fn-type="con"><p>Authorship: N.C. conceptualized the review, analyzed and interpreted the data, and wrote the manuscript. M.M.M. and J.D. undertook the comprehensive literature search. All authors did coding, provided technical and material support, and involved in manuscript review and editing. N.C. has full access to all the data and takes responsibility for the integrity of the data and the accuracy of the data analysis.</p></fn></fn-group><ref-list><title>Reference List</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><collab>CDC</collab><article-title>Monitoring selected national HIV prevention and care objectives by using HIV surveillance data - United States and 6 dependent area, 2011</article-title><source>HIV Surveillance Report</source><year>2013</year><volume>18</volume><comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/hiv/library/reports/surveillance">http://www.cdc.gov/hiv/library/reports/surveillance</ext-link>. Published October 2013</comment><date-in-citation>Accessed 15 November 2013</date-in-citation></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><collab>CDC</collab><article-title>estimated HIV incidence in the United States, 2007&#x02013;2010. HIV Suveillance Supplemental Report</article-title><source>HIV Surveillance Supplemental Report</source><year>2012</year><volume>17</volume><issue>4</issue><comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/hiv/surveillance/resources/reports/2010supp_vol17no4/">http://www.cdc.gov/hiv/surveillance/resources/reports/2010supp_vol17no4/</ext-link>. Published December 2012</comment><date-in-citation>Accessed 11 April 2013</date-in-citation></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname><given-names>G</given-names></name><name><surname>Crepaz</surname><given-names>N</given-names></name><name><surname>Senterfitt</surname><given-names>JW</given-names></name><name><surname>Janssen</surname><given-names>RS</given-names></name></person-group><article-title>Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs</article-title><source>J Acquir Immune Defic Syndr</source><year>2005</year><volume>39</volume><fpage>446</fpage><lpage>453</lpage><pub-id pub-id-type="pmid">16010168</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallabhaneni</surname><given-names>S</given-names></name><name><surname>McConnell</surname><given-names>JJ</given-names></name><name><surname>Loeb</surname><given-names>L</given-names></name><name><surname>Hartogensis</surname><given-names>W</given-names></name><name><surname>Hecht</surname><given-names>FM</given-names></name><name><surname>Grant</surname><given-names>RM</given-names></name><etal/></person-group><article-title>Changes in seroadaptive practices from before to after diagnosis of recent HIV infection among men who have sex with men</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e55397</fpage><pub-id pub-id-type="pmid">23405145</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>JM</given-names></name><name><surname>McNaghten</surname><given-names>AD</given-names></name><name><surname>Frazier</surname><given-names>EL</given-names></name><name><surname>Skarbinski</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Heffelfinger</surname><given-names>JD</given-names></name></person-group><article-title>Clinical and Behavioral Characteristics of Adults Receiving Medical Care for HIV Infection --- Medical Monitoring Project, United States, 2007</article-title><source>MMWR Surveill Summ</source><year>2011</year><volume>60</volume><fpage>1</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">21881551</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crepaz</surname><given-names>N</given-names></name><name><surname>Marks</surname><given-names>G</given-names></name><name><surname>Liau</surname><given-names>A</given-names></name><name><surname>Mullins</surname><given-names>MM</given-names></name><name><surname>Aupont</surname><given-names>LW</given-names></name><name><surname>Marshall</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Prevalence of unprotected anal intercourse among HIV-diagnosed MSM in the United States: a meta-analysis</article-title><source>AIDS</source><year>2009</year><volume>23</volume><fpage>1617</fpage><lpage>1629</lpage><pub-id pub-id-type="pmid">19584704</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="book"><collab>Office of National AIDS Policy</collab><source>National HIV/AIDS strategy for the United States</source><publisher-loc>Washington, DC</publisher-loc><publisher-name>Office of National AIDS Policy</publisher-name><comment><ext-link ext-link-type="uri" xlink:href="http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf">http://www.whitehouse.gov/sites/default/files/uploads/NHAS.pdf</ext-link>. Published July 2010</comment><date-in-citation>Accessed 4 February 2013</date-in-citation></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crepaz</surname><given-names>N</given-names></name><name><surname>Lyles</surname><given-names>CM</given-names></name><name><surname>Wolitski</surname><given-names>RJ</given-names></name><name><surname>Passin</surname><given-names>WF</given-names></name><name><surname>Rama</surname><given-names>SM</given-names></name><name><surname>Herbst</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials</article-title><source>AIDS</source><year>2006</year><volume>20</volume><fpage>143</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">16511407</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>BT</given-names></name><name><surname>Carey</surname><given-names>MP</given-names></name><name><surname>Chaudoir</surname><given-names>SR</given-names></name><name><surname>Reid</surname><given-names>AE</given-names></name></person-group><article-title>Sexual risk reduction for persons living with HIV: research synthesis of randomized controlled trials, 1993 to 2004</article-title><source>J Acquir Immune Defic Syndr</source><year>2006</year><volume>41</volume><fpage>642</fpage><lpage>650</lpage><pub-id pub-id-type="pmid">16652039</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>CE</given-names></name><name><surname>Medley</surname><given-names>AM</given-names></name><name><surname>Sweat</surname><given-names>MD</given-names></name><name><surname>O&#x02019;Reilly</surname><given-names>KR</given-names></name></person-group><article-title>Behavioural interventions for HIV positive prevention in developing countries: a systematic review and meta-analysis</article-title><source>Bull World Health Organ</source><year>2010</year><volume>88</volume><fpage>615</fpage><lpage>623</lpage><pub-id pub-id-type="pmid">20680127</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Higgins</surname><given-names>JPT</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Sterne</surname><given-names>JAC</given-names></name><name><surname>Green</surname><given-names>S</given-names></name></person-group><article-title>Chapter 8: Assessing the risk of bias in included studies</article-title><source>Cochrane Handbook for Systematic Review of Interventions Version 5.1.0 [updated March 2011]</source><publisher-name>The Cochrane Handbook</publisher-name><year>2011</year><comment><ext-link ext-link-type="uri" xlink:href="www.cochrane-handbook.org">www.cochrane-handbook.org</ext-link></comment></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="book"><source>Methods Guide for Effectiveness and Comparative Effectiveness Reviews</source><comment>AHRQ Publication No.10(13)-EHC063-EF</comment><publisher-loc>Rockville, MD</publisher-loc><publisher-name>Agency for Healthcare Research and Quality</publisher-name><month>9</month><year>2013</year><comment>Chapters available at: <ext-link ext-link-type="uri" xlink:href="www.effectivehealthcare.ahrq.gov">www.effectivehealthcare.ahrq.gov</ext-link></comment></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyles</surname><given-names>CM</given-names></name><name><surname>Kay</surname><given-names>LS</given-names></name><name><surname>Crepaz</surname><given-names>N</given-names></name><name><surname>Herbst</surname><given-names>JH</given-names></name><name><surname>Passin</surname><given-names>WF</given-names></name><name><surname>Kim</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk, 2000&#x02013;2004</article-title><source>Am J Public Health</source><year>2007</year><volume>97</volume><fpage>133</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">17138920</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="web"><collab>Prevention Research Synthesis (PRS) Project</collab><source>HIV Risk Reduction Efficacy Review: Efficacy Criteria</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/hiv/topics/research/prs/efficacy_criteria.htm">http://www.cdc.gov/hiv/topics/research/prs/efficacy_criteria.htm</ext-link></comment><date-in-citation>Accessed 15 April 2013</date-in-citation></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="web"><source>The Guide to Community Preventive Services (The Community Guide)</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.thecommunityguide.org/index.html">http://www.thecommunityguide.org/index.html</ext-link></comment><date-in-citation>Accessed 15 April 2013</date-in-citation></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="web"><collab>U.S Department of Health and Human Services, Office of Adolescent Health</collab><source>Teen Pregnancy Prevention: Evidence-Based Programs</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.hhs.gov/ash/oah/oah-initiatives/tpp/tpp-database.html">http://www.hhs.gov/ash/oah/oah-initiatives/tpp/tpp-database.html</ext-link></comment><date-in-citation>Accessed 4 February 2013</date-in-citation></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="web"><collab>U.S. Department of Justice. Office of Justice Crime Solutions</collab><comment><ext-link ext-link-type="uri" xlink:href="http://www.crimesolutions.gov/">http://www.crimesolutions.gov/</ext-link></comment><date-in-citation>Accessed 4 February 2013</date-in-citation></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="web"><collab>Grade of Recommendations Assessment, Development and Evaluation (GRADE) Working Group</collab><comment><ext-link ext-link-type="uri" xlink:href="http://www.gradeworkinggroup.org/index.htm">http://www.gradeworkinggroup.org/index.htm</ext-link></comment><date-in-citation>Accessed 15 April 2013</date-in-citation></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="web"><collab>Substance Abuse and Mental Health Services Administration SAMHSA</collab><comment><ext-link ext-link-type="uri" xlink:href="http://www.samhsa.gov/">http://www.samhsa.gov/</ext-link></comment><date-in-citation>Accessed 15 April 2013</date-in-citation></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="web"><collab>SAMHSA Substance Abuse and Mental Health Services Administration</collab><source>NREPP - National Registry of Evidence-Based Programs and Practices</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.nrepp.samhsa.gov/">http://www.nrepp.samhsa.gov/</ext-link></comment><date-in-citation>Accessed 4 February 2013</date-in-citation></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeLuca</surname><given-names>JB</given-names></name><name><surname>Mullins</surname><given-names>MM</given-names></name><name><surname>Lyles</surname><given-names>CM</given-names></name><name><surname>Crepaz</surname><given-names>N</given-names></name><name><surname>Kay</surname><given-names>L</given-names></name><name><surname>Thadiparthi</surname><given-names>S</given-names></name></person-group><article-title>Developing a comprehensive search strategy for evidence-based systematic review</article-title><source>Evid Based Libr Inf Pract</source><year>2011</year><volume>3</volume><fpage>3</fpage><lpage>32</lpage></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="book"><source>OVID-EMBASE [database online]</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Wolters, Kluwer</publisher-name><year>1988</year></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="book"><source>OVID-MEDLINE [database online]</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Wolters Kluwer</publisher-name><year>1988</year></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="book"><source>OVID-PsycINFO [database online]</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Wolters Kluwer</publisher-name><year>1988</year></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="book"><source>ProQuest- Sociological Abstracts [database online]</source><publisher-loc>Ann Arbor, MI</publisher-loc><publisher-name>Cambridge Information Group</publisher-name><year>2000</year></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="book"><source>ISI Web of Knowledge [Database Online]</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Thomson Reuters</publisher-name><year>2013</year></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="web"><collab>U.S. Department of Health and Human Services</collab><source>NIH Research Portfolio Online Reporting Tools Expenditures (RePORT)</source><comment><ext-link ext-link-type="uri" xlink:href="http://projectreporter.nih.gov/reporter.cfm">http://projectreporter.nih.gov/reporter.cfm</ext-link></comment><date-in-citation>Accessed 15 April 2013</date-in-citation></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="book"><source>The Cochrane Library [Database Online]</source><publisher-loc>Oxford, UK</publisher-loc><publisher-name>John Wiley &#x00026; Sons, Ltd</publisher-name><year>2013</year></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naar-King</surname><given-names>S</given-names></name><name><surname>Wright</surname><given-names>K</given-names></name><name><surname>Parsons</surname><given-names>JT</given-names></name><name><surname>Frey</surname><given-names>M</given-names></name><name><surname>Templin</surname><given-names>T</given-names></name><name><surname>Lam</surname><given-names>P</given-names></name><etal/></person-group><article-title>Healthy choices: motivational enhancement therapy for health risk behaviors in HIV-positive youth</article-title><source>AIDS Educ Prev</source><year>2006</year><volume>18</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">16539572</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Murphy</surname><given-names>DA</given-names></name><name><surname>Naar-King</surname><given-names>S</given-names></name><name><surname>Parsons</surname><given-names>JT</given-names></name></person-group><article-title>A clinic-based motivational intervention improves condom use among subgroups of youth living with HIV</article-title><source>J Adolesc Health</source><year>2011</year><volume>49</volume><fpage>193</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">21783053</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><collab>Healthy Living Project Team</collab><article-title>Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: the healthy living project randomized controlled study</article-title><source>J Acquir Immune Defic Syndr</source><year>2007</year><volume>44</volume><fpage>213</fpage><lpage>221</lpage><pub-id pub-id-type="pmid">17146375</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleary</surname><given-names>PD</given-names></name><name><surname>Van</surname><given-names>DN</given-names></name><name><surname>Steilen</surname><given-names>M</given-names></name><name><surname>Stuart</surname><given-names>A</given-names></name><name><surname>Shipton-Levy</surname><given-names>R</given-names></name><name><surname>McMullen</surname><given-names>W</given-names></name><etal/></person-group><article-title>A randomized trial of an education and support program for HIV-infected individuals</article-title><source>AIDS</source><year>1995</year><volume>9</volume><fpage>1271</fpage><lpage>1278</lpage><pub-id pub-id-type="pmid">8561981</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coates</surname><given-names>TJ</given-names></name><name><surname>McKusick</surname><given-names>L</given-names></name><name><surname>Kuno</surname><given-names>R</given-names></name><name><surname>Stites</surname><given-names>DP</given-names></name></person-group><article-title>Stress reduction training changed number of sexual partners but not immune function in men with HIV</article-title><source>Am J Public Health</source><year>1989</year><volume>79</volume><fpage>885</fpage><lpage>887</lpage><pub-id pub-id-type="pmid">2735479</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coleman</surname><given-names>CL</given-names></name><name><surname>Jemmott</surname><given-names>L</given-names></name><name><surname>Jemmott</surname><given-names>JB</given-names></name><name><surname>Strumpf</surname><given-names>N</given-names></name><name><surname>Ratcliffe</surname><given-names>S</given-names></name></person-group><article-title>Development of an HIV risk reduction intervention for older seropositive African American men</article-title><source>AIDS Patient Care STDS</source><year>2009</year><volume>23</volume><fpage>647</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">19591604</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cosio</surname><given-names>D</given-names></name><name><surname>Heckman</surname><given-names>TG</given-names></name><name><surname>Anderson</surname><given-names>T</given-names></name><name><surname>Heckman</surname><given-names>BD</given-names></name><name><surname>Garske</surname><given-names>J</given-names></name><name><surname>McCarthy</surname><given-names>J</given-names></name></person-group><article-title>Telephone-administered motivational interviewing to reduce risky sexual behavior in HIV-infected rural persons: a pilot randomized clinical trial</article-title><source>Sex Transm Dis</source><year>2010</year><volume>37</volume><fpage>140</fpage><lpage>146</lpage><pub-id pub-id-type="pmid">20118830</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Bassel</surname><given-names>N</given-names></name><name><surname>Jemmott</surname><given-names>JB</given-names></name><name><surname>Landis</surname><given-names>JR</given-names></name><name><surname>Pequegnat</surname><given-names>W</given-names></name><name><surname>Wingood</surname><given-names>GM</given-names></name><name><surname>Wyatt</surname><given-names>GE</given-names></name><etal/></person-group><article-title>National Institute of Mental Health Multisite Eban HIV/STD Prevention Intervention for African American HIV Serodiscordant Couples: a cluster randomized trial</article-title><source>Arch Intern Med</source><year>2010</year><volume>170</volume><fpage>1594</fpage><lpage>1601</lpage><pub-id pub-id-type="pmid">20625011</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>JD</given-names></name><name><surname>Fisher</surname><given-names>WA</given-names></name><name><surname>Cornman</surname><given-names>DH</given-names></name><name><surname>Amico</surname><given-names>RK</given-names></name><name><surname>Bryan</surname><given-names>A</given-names></name><name><surname>Friedland</surname><given-names>GH</given-names></name></person-group><article-title>Clinician-delivered intervention during routine clinical care reduces unprotected sexual behavior among HIV-infected patients</article-title><source>J Acquir Immune Defic Syndr</source><year>2006</year><volume>41</volume><fpage>44</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">16340472</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogarty</surname><given-names>LA</given-names></name><name><surname>Heilig</surname><given-names>CM</given-names></name><name><surname>Armstrong</surname><given-names>K</given-names></name><name><surname>Cabral</surname><given-names>R</given-names></name><name><surname>Galavotti</surname><given-names>C</given-names></name><name><surname>Gielen</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Long-term effectiveness of a peer-based intervention to promote condom and contraceptive use among HIV-positive and at-risk women</article-title><source>Public Health Rep</source><year>2001</year><volume>116</volume><issue>Suppl 1</issue><fpage>103</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">11889279</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>P</given-names></name><name><surname>Ciccarone</surname><given-names>D</given-names></name><name><surname>Gansky</surname><given-names>SA</given-names></name><name><surname>Bangsberg</surname><given-names>DR</given-names></name><name><surname>Clanon</surname><given-names>K</given-names></name><name><surname>McPhee</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Interactive &#x0201c;Video Doctor&#x0201d; counseling reduces drug and sexual risk behaviors among HIV-positive patients in diverse outpatient settings</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e1988</fpage><pub-id pub-id-type="pmid">18431475</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golin</surname><given-names>CE</given-names></name><name><surname>Davis</surname><given-names>RA</given-names></name><name><surname>Przybyla</surname><given-names>SM</given-names></name><name><surname>Fowler</surname><given-names>B</given-names></name><name><surname>Parker</surname><given-names>S</given-names></name><name><surname>Earp</surname><given-names>JA</given-names></name><etal/></person-group><article-title>SafeTalk, a multicomponent, motivational interviewing-based, safer sex counseling program for people living with HIV/AIDS: a qualitative assessment of patients&#x02019; views</article-title><source>AIDS Patient Care STDS</source><year>2010</year><volume>24</volume><fpage>237</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">20377435</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grinstead</surname><given-names>O</given-names></name><name><surname>Zack</surname><given-names>B</given-names></name><name><surname>Faigeles</surname><given-names>B</given-names></name></person-group><article-title>Reducing postrelease risk behavior among HIV seropositive prison inmates: the health promotion program</article-title><source>AIDS Educ Prev</source><year>2001</year><volume>13</volume><fpage>109</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">11398956</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holstad</surname><given-names>MM</given-names></name><name><surname>DiIorio</surname><given-names>C</given-names></name><name><surname>Kelley</surname><given-names>ME</given-names></name><name><surname>Resnicow</surname><given-names>K</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name></person-group><article-title>Group motivational interviewing to promote adherence to antiretroviral medications and risk reduction behaviors in HIV infected women</article-title><source>AIDS Behav</source><year>2011</year><volume>15</volume><fpage>885</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">21165692</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Illa</surname><given-names>L</given-names></name><name><surname>Echenique</surname><given-names>M</given-names></name><name><surname>Jean</surname><given-names>GS</given-names></name><name><surname>Bustamante-Avellaneda</surname><given-names>V</given-names></name><name><surname>Metsch</surname><given-names>L</given-names></name><name><surname>Mendez-Mulet</surname><given-names>L</given-names></name><etal/></person-group><article-title>Project ROADMAP: Reeducating Older Adults in Maintaining AIDS Prevention: a secondary intervention for older HIV-positive adults</article-title><source>AIDS Educ Prev</source><year>2010</year><volume>22</volume><fpage>138</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">20387984</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalichman</surname><given-names>SC</given-names></name><name><surname>Rompa</surname><given-names>D</given-names></name><name><surname>Cage</surname><given-names>M</given-names></name><name><surname>DiFonzo</surname><given-names>K</given-names></name><name><surname>Simpson</surname><given-names>D</given-names></name><name><surname>Austin</surname><given-names>J</given-names></name><etal/></person-group><article-title>Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people</article-title><source>Am J Prev Med</source><year>2001</year><volume>21</volume><fpage>84</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">11457627</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalichman</surname><given-names>SC</given-names></name><name><surname>Cherry</surname><given-names>C</given-names></name><name><surname>Kalichman</surname><given-names>MO</given-names></name><name><surname>Amaral</surname><given-names>CM</given-names></name><name><surname>White</surname><given-names>D</given-names></name><name><surname>Pope</surname><given-names>H</given-names></name><etal/></person-group><article-title>Integrated behavioral intervention to improve HIV/AIDS treatment adherence and reduce HIV transmission</article-title><source>Am J Public Health</source><year>2011</year><volume>101</volume><fpage>531</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">21233431</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>JA</given-names></name><name><surname>Murphy</surname><given-names>DA</given-names></name><name><surname>Bahr</surname><given-names>GR</given-names></name><name><surname>Kalichman</surname><given-names>SC</given-names></name><name><surname>Morgan</surname><given-names>MG</given-names></name><name><surname>Stevenson</surname><given-names>LY</given-names></name><etal/></person-group><article-title>Outcome of cognitive-behavioral and support group brief therapies for depressed, HIV-infected persons</article-title><source>Am J Psychiatry</source><year>1993</year><volume>150</volume><fpage>1679</fpage><lpage>1686</lpage><pub-id pub-id-type="pmid">8214177</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapinski</surname><given-names>MK</given-names></name><name><surname>Randall</surname><given-names>LM</given-names></name><name><surname>Peterson</surname><given-names>M</given-names></name><name><surname>Peterson</surname><given-names>A</given-names></name><name><surname>Klein</surname><given-names>KA</given-names></name></person-group><article-title>Prevention options for positives: the effects of a health communication intervention for men who have sex with men living with HIV/AIDS</article-title><source>Health Commun</source><year>2009</year><volume>24</volume><fpage>562</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">19735033</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lightfoot</surname><given-names>M</given-names></name><name><surname>Rotheram-Borus</surname><given-names>MJ</given-names></name><name><surname>Comulada</surname><given-names>WS</given-names></name><name><surname>Reddy</surname><given-names>VS</given-names></name><name><surname>Duan</surname><given-names>N</given-names></name></person-group><article-title>Efficacy of brief interventions in clinical care settings for persons living with HIV</article-title><source>J Acquir Immune Defic Syndr</source><year>2010</year><volume>53</volume><fpage>348</fpage><lpage>356</lpage><pub-id pub-id-type="pmid">19996978</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovejoy</surname><given-names>TI</given-names></name><name><surname>Heckman</surname><given-names>TG</given-names></name><name><surname>Suhr</surname><given-names>JA</given-names></name><name><surname>Anderson</surname><given-names>T</given-names></name><name><surname>Heckman</surname><given-names>BD</given-names></name><name><surname>France</surname><given-names>CR</given-names></name></person-group><article-title>Telephone-administered motivational interviewing reduces risky sexual behavior in HIV-positive late middle-age and older adults: a pilot randomized controlled trial</article-title><source>AIDS Behav</source><year>2011</year><volume>15</volume><fpage>1623</fpage><lpage>1634</lpage><pub-id pub-id-type="pmid">21809048</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margolin</surname><given-names>A</given-names></name><name><surname>Avants</surname><given-names>SK</given-names></name><name><surname>Warburton</surname><given-names>LA</given-names></name><name><surname>Hawkins</surname><given-names>KA</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name></person-group><article-title>A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users</article-title><source>Health Psychol</source><year>2003</year><volume>22</volume><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">12683743</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margolin</surname><given-names>A</given-names></name><name><surname>Schuman-Olivier</surname><given-names>Z</given-names></name><name><surname>Beitel</surname><given-names>M</given-names></name><name><surname>Arnold</surname><given-names>RM</given-names></name><name><surname>Fulwiler</surname><given-names>CE</given-names></name><name><surname>Avants</surname><given-names>SK</given-names></name></person-group><article-title>A preliminary study of spiritual self-schema (3-S(+)) therapy for reducing impulsivity in HIV-positive drug users</article-title><source>J Clin Psychol</source><year>2007</year><volume>63</volume><fpage>979</fpage><lpage>999</lpage><pub-id pub-id-type="pmid">17828761</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mausbach</surname><given-names>BT</given-names></name><name><surname>Semple</surname><given-names>SJ</given-names></name><name><surname>Strathdee</surname><given-names>SA</given-names></name><name><surname>Zians</surname><given-names>J</given-names></name><name><surname>Patterson</surname><given-names>TL</given-names></name></person-group><article-title>Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: results from the EDGE study</article-title><source>Drug Alcohol Depend</source><year>2007</year><volume>87</volume><fpage>249</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">17182196</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>McCoy</surname><given-names>HV</given-names></name><name><surname>Dodds</surname><given-names>S</given-names></name><name><surname>Rivers</surname><given-names>JE</given-names></name><name><surname>McCoy</surname><given-names>CB</given-names></name></person-group><article-title>Case management services for HIV-seropositive IDUs</article-title><source>Progress and issues in case management</source><person-group person-group-type="editor"><name><surname>Ashery</surname><given-names>RS</given-names></name></person-group><publisher-loc>Rockville, MD</publisher-loc><publisher-name>National Institute on Drug Abuse</publisher-name><year>1992</year><fpage>181</fpage><lpage>207</lpage></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKirnan</surname><given-names>DJ</given-names></name><name><surname>Tolou-Shams</surname><given-names>M</given-names></name><name><surname>Courtenay-Quirk</surname><given-names>C</given-names></name></person-group><article-title>The Treatment Advocacy Program: a randomized controlled trial of a peer-led safer sex intervention for HIV-infected men who have sex with men</article-title><source>J Consult Clin Psychol</source><year>2010</year><volume>78</volume><fpage>952</fpage><lpage>963</lpage><pub-id pub-id-type="pmid">20919760</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metsch</surname><given-names>LR</given-names></name><name><surname>Pereyra</surname><given-names>M</given-names></name><name><surname>Messinger</surname><given-names>S</given-names></name><name><surname>del Rio</surname><given-names>C</given-names></name><name><surname>Strathdee</surname><given-names>SA</given-names></name><name><surname>Anderson-Mahoney</surname><given-names>P</given-names></name><etal/></person-group><article-title>HIV transmission risk behaviors among HIV-infected persons who are successfully linked to care</article-title><source>Clinical Infectious Diseases</source><year>2008</year><volume>47</volume><fpage>577</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">18624629</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patterson</surname><given-names>TL</given-names></name><name><surname>Shaw</surname><given-names>WS</given-names></name><name><surname>Semple</surname><given-names>SJ</given-names></name></person-group><article-title>Reducing the sexual risk behaviors of HIV+ individuals: outcome of a randomized controlled trial</article-title><source>Ann Behav Med</source><year>2003</year><volume>25</volume><fpage>137</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">12704016</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petry</surname><given-names>NM</given-names></name><name><surname>Weinstock</surname><given-names>J</given-names></name><name><surname>Alessi</surname><given-names>SM</given-names></name><name><surname>Lewis</surname><given-names>MW</given-names></name><name><surname>Dieckhaus</surname><given-names>K</given-names></name></person-group><article-title>Group-based randomized trial of contingencies for health and abstinence in HIV patients</article-title><source>J Consult Clin Psychol</source><year>2010</year><volume>78</volume><fpage>89</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">20099954</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purcell</surname><given-names>DW</given-names></name><name><surname>Latka</surname><given-names>MH</given-names></name><name><surname>Metsch</surname><given-names>LR</given-names></name><name><surname>Latkin</surname><given-names>CA</given-names></name><name><surname>Gomez</surname><given-names>CA</given-names></name><name><surname>Mizuno</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Results from a randomized controlled trial of a peer-mentoring intervention to reduce HIV transmission and increase access to care and adherence to HIV medications among HIV-seropositive injection drug users</article-title><source>J Acquir Immune Defic Syndr</source><year>2007</year><volume>46</volume><issue>Suppl 2</issue><fpage>S35</fpage><lpage>S47</lpage><pub-id pub-id-type="pmid">18089983</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>JL</given-names></name><name><surname>Milam</surname><given-names>J</given-names></name><name><surname>McCutchan</surname><given-names>A</given-names></name><name><surname>Stoyanoff</surname><given-names>S</given-names></name><name><surname>Bolan</surname><given-names>R</given-names></name><name><surname>Weiss</surname><given-names>J</given-names></name><etal/></person-group><article-title>Effect of brief safer-sex counseling by medical providers to HIV-1 seropositive patients: A multi-clinic assessment</article-title><source>AIDS</source><year>2004</year><volume>18</volume><fpage>1179</fpage><lpage>1186</lpage><pub-id pub-id-type="pmid">15166533</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>CD</given-names></name><name><surname>Courtenay-Quirk</surname><given-names>C</given-names></name><name><surname>Knight</surname><given-names>K</given-names></name><name><surname>Shade</surname><given-names>SB</given-names></name><name><surname>Vittinghoff</surname><given-names>E</given-names></name><name><surname>Gomez</surname><given-names>C</given-names></name><etal/></person-group><article-title>HIV intervention for providers study: a randomized controlled trial of a clinician-delivered HIV risk-reduction intervention for HIV-positive people</article-title><source>J Acquir Immune Defic Syndr</source><year>2010</year><volume>55</volume><fpage>572</fpage><lpage>581</lpage><pub-id pub-id-type="pmid">20827218</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosser</surname><given-names>BR</given-names></name><name><surname>Hatfield</surname><given-names>LA</given-names></name><name><surname>Miner</surname><given-names>MH</given-names></name><name><surname>Ghiselli</surname><given-names>ME</given-names></name><name><surname>Lee</surname><given-names>BR</given-names></name><name><surname>Welles</surname><given-names>SL</given-names></name></person-group><article-title>Effects of a behavioral intervention to reduce serodiscordant unsafe sex among HIV positive men who have sex with men: the Positive Connections randomized controlled trial study</article-title><source>J Behav Med</source><year>2010</year><volume>33</volume><fpage>147</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">20101454</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotheram-Borus</surname><given-names>MJ</given-names></name><name><surname>Lee</surname><given-names>MB</given-names></name><name><surname>Murphy</surname><given-names>DA</given-names></name><name><surname>Futterman</surname><given-names>D</given-names></name><name><surname>Duan</surname><given-names>N</given-names></name><name><surname>Birnbaum</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Efficacy of a preventive intervention for youths living with HIV</article-title><source>Am J Public Health</source><year>2001</year><volume>91</volume><fpage>400</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">11236404</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotheram-Borus</surname><given-names>MJ</given-names></name><name><surname>Swendeman</surname><given-names>D</given-names></name><name><surname>Comulada</surname><given-names>WS</given-names></name><name><surname>Weiss</surname><given-names>RE</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Lightfoot</surname><given-names>M</given-names></name></person-group><article-title>Prevention for substance-using HIV-positive young people: telephone and in-person delivery</article-title><source>J Acquir Immune Defic Syndr</source><year>2004</year><volume>37</volume><issue>Suppl 2</issue><fpage>S68</fpage><lpage>S77</lpage><pub-id pub-id-type="pmid">15385902</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safren</surname><given-names>SA</given-names></name><name><surname>O&#x02019;Cleirigh</surname><given-names>CM</given-names></name><name><surname>Skeer</surname><given-names>M</given-names></name><name><surname>Elsesser</surname><given-names>SA</given-names></name><name><surname>Mayer</surname><given-names>KH</given-names></name></person-group><article-title>Project enhance: A randomized controlled trial of an individualized HIV prevention intervention for HIV-infected men who have sex with men conducted in a primary care setting</article-title><source>Health Psychol</source><year>2013</year><volume>32</volume><fpage>171</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">22746262</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarcz</surname><given-names>SK</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Murphy</surname><given-names>JL</given-names></name><name><surname>Paul</surname><given-names>JP</given-names></name><name><surname>Skinta</surname><given-names>MD</given-names></name><name><surname>Scheer</surname><given-names>S</given-names></name><etal/></person-group><article-title>A randomized control trial of personalized cognitive counseling to reduce sexual risk among HIV-infected men who have sex with men</article-title><source>AIDS Care</source><year>2013</year><volume>25</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">22568569</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serovich</surname><given-names>JM</given-names></name><name><surname>Reed</surname><given-names>S</given-names></name><name><surname>Grafsky</surname><given-names>EL</given-names></name><name><surname>Andrist</surname><given-names>D</given-names></name></person-group><article-title>An intervention to assist men who have sex with men disclose their serostatus to casual sex partners: results from a pilot study</article-title><source>AIDS Educ Prev</source><year>2009</year><volume>21</volume><fpage>207</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">19519236</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sikkema</surname><given-names>KJ</given-names></name><name><surname>Wilson</surname><given-names>PA</given-names></name><name><surname>Hansen</surname><given-names>NB</given-names></name><name><surname>Kochman</surname><given-names>A</given-names></name><name><surname>Neufeld</surname><given-names>S</given-names></name><name><surname>Ghebremichael</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Effects of a coping intervention on transmission risk behavior among people living with HIV/AIDS and a history of childhood sexual abuse</article-title><source>J Acquir Immune Defic Syndr</source><year>2008</year><volume>47</volume><fpage>506</fpage><lpage>513</lpage><pub-id pub-id-type="pmid">18176319</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sikkema</surname><given-names>KJ</given-names></name><name><surname>Hansen</surname><given-names>NB</given-names></name><name><surname>Kochman</surname><given-names>A</given-names></name><name><surname>Santos</surname><given-names>J</given-names></name><name><surname>Watt</surname><given-names>MH</given-names></name><name><surname>Wilson</surname><given-names>PA</given-names></name><etal/></person-group><article-title>The development and feasibility of a brief risk reduction intervention for newly HIV-diagnosed men who have sex with men</article-title><source>Journal of Community Psychology</source><year>2011</year><volume>39</volume><fpage>717</fpage><lpage>732</lpage><pub-id pub-id-type="pmid">22228917</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sorensen</surname><given-names>JL</given-names></name><name><surname>Dilley</surname><given-names>J</given-names></name><name><surname>London</surname><given-names>J</given-names></name><name><surname>Okin</surname><given-names>RL</given-names></name><name><surname>Delucchi</surname><given-names>KL</given-names></name><name><surname>Phibbs</surname><given-names>CS</given-names></name></person-group><article-title>Case management for substance abusers with HIV/AIDS: a randomized clinical trial</article-title><source>Am J Drug Alcohol Abuse</source><year>2003</year><volume>29</volume><fpage>133</fpage><lpage>150</lpage><pub-id pub-id-type="pmid">12731685</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teti</surname><given-names>M</given-names></name><name><surname>Bowleg</surname><given-names>L</given-names></name><name><surname>Cole</surname><given-names>R</given-names></name><name><surname>Lloyd</surname><given-names>L</given-names></name><name><surname>Rubinstein</surname><given-names>S</given-names></name><name><surname>Spencer</surname><given-names>S</given-names></name><etal/></person-group><article-title>A mixed methods evaluation of the effect of the protect and respect intervention on the condom use and disclosure practices of women living with HIV/AIDS</article-title><source>AIDS Behav</source><year>2010</year><volume>14</volume><fpage>567</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">19357943</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velasquez</surname><given-names>MM</given-names></name><name><surname>von</surname><given-names>SK</given-names></name><name><surname>Johnson</surname><given-names>DH</given-names></name><name><surname>Green</surname><given-names>C</given-names></name><name><surname>Carbonari</surname><given-names>JP</given-names></name><name><surname>Parsons</surname><given-names>JT</given-names></name></person-group><article-title>Reducing sexual risk behaviors and alcohol use among HIV-positive men who have sex with men: a randomized clinical trial</article-title><source>J Consult Clin Psychol</source><year>2009</year><volume>77</volume><fpage>657</fpage><lpage>667</lpage><pub-id pub-id-type="pmid">19634959</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JK</given-names></name><name><surname>Wyatt</surname><given-names>GE</given-names></name><name><surname>Rivkin</surname><given-names>I</given-names></name><name><surname>Ramamurthi</surname><given-names>HC</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name></person-group><article-title>Risk reduction for HIV-positive African American and Latino men with histories of childhood sexual abuse</article-title><source>Arch Sex Behav</source><year>2008</year><volume>37</volume><fpage>763</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">18506611</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>M</given-names></name><name><surname>Bowen</surname><given-names>A</given-names></name><name><surname>Atkinson</surname><given-names>JS</given-names></name><name><surname>Nilsson-Schonnesson</surname><given-names>L</given-names></name><name><surname>Diamond</surname><given-names>PM</given-names></name><name><surname>Ross</surname><given-names>MW</given-names></name><etal/></person-group><article-title>An assessment of brief group interventions to increase condom use by heterosexual crack smokers living with HIV infection</article-title><source>AIDS Care</source><year>2012</year><volume>24</volume><fpage>220</fpage><lpage>231</lpage><pub-id pub-id-type="pmid">21780981</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingood</surname><given-names>GM</given-names></name><name><surname>DiClemente</surname><given-names>RJ</given-names></name><name><surname>Mikhail</surname><given-names>I</given-names></name><name><surname>Lang</surname><given-names>DL</given-names></name><name><surname>McCree</surname><given-names>DH</given-names></name><name><surname>Davies</surname><given-names>SL</given-names></name><etal/></person-group><article-title>A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program</article-title><source>J Acquir Immune Defic Syndr</source><year>2004</year><volume>37</volume><issue>Suppl 2</issue><fpage>S58</fpage><lpage>S67</lpage><pub-id pub-id-type="pmid">15385901</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolitski</surname><given-names>RJ</given-names></name><name><surname>Gomez</surname><given-names>CA</given-names></name><name><surname>Parsons</surname><given-names>JT</given-names></name></person-group><article-title>Effects of a peer-led behavioral intervention to reduce HIV transmission and promote serostatus disclosure among HIV-seropositive gay and bisexual men</article-title><source>AIDS</source><year>2005</year><volume>19</volume><issue>Suppl 1</issue><fpage>S99</fpage><lpage>S109</lpage><pub-id pub-id-type="pmid">15838199</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolitski</surname><given-names>RJ</given-names></name><name><surname>Kidder</surname><given-names>DP</given-names></name><name><surname>Pals</surname><given-names>SL</given-names></name><name><surname>Royal</surname><given-names>S</given-names></name><name><surname>Aidala</surname><given-names>A</given-names></name><name><surname>Stall</surname><given-names>R</given-names></name><etal/></person-group><article-title>Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV</article-title><source>AIDS Behav</source><year>2010</year><volume>14</volume><fpage>493</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">19949848</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wyatt</surname><given-names>GE</given-names></name><name><surname>Longshore</surname><given-names>D</given-names></name><name><surname>Chin</surname><given-names>D</given-names></name><name><surname>Carmona</surname><given-names>JV</given-names></name><name><surname>Loeb</surname><given-names>TB</given-names></name><name><surname>Myers</surname><given-names>HF</given-names></name><etal/></person-group><article-title>The efficacy of an integrated risk reduction intervention for HIV-positive women with child sexual abuse histories</article-title><source>AIDS Behav</source><year>2004</year><volume>8</volume><fpage>453</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">15690118</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bandura</surname><given-names>A</given-names></name></person-group><source>Social Foundations of Thought and Action: A Social Cognitive Theory</source><publisher-loc>Englewood Cliffs, NJ</publisher-loc><publisher-name>Prentice-Hall</publisher-name><year>1986</year></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>JD</given-names></name><name><surname>Fisher</surname><given-names>WA</given-names></name><name><surname>Williams</surname><given-names>SS</given-names></name><name><surname>Malloy</surname><given-names>TE</given-names></name></person-group><article-title>Empirical tests of an information-motivation-behavioral skills model of AIDS-preventive behavior with gay men and heterosexual university students</article-title><source>Health Psychol</source><year>1994</year><volume>13</volume><fpage>238</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">8055859</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>JD</given-names></name><name><surname>Fisher</surname><given-names>WA</given-names></name><name><surname>Misovich</surname><given-names>SJ</given-names></name><name><surname>Kimble</surname><given-names>DL</given-names></name><name><surname>Malloy</surname><given-names>TE</given-names></name></person-group><article-title>Changing AIDS risk behavior: effects of an intervention emphasizing AIDS risk reduction information, motivation, and behavioral skills in a college student population</article-title><source>Health Psychol</source><year>1996</year><volume>15</volume><fpage>114</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">8681919</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Fishbein</surname><given-names>M</given-names></name><name><surname>Ajzen</surname><given-names>I</given-names></name></person-group><source>Belief, Attitude, Intention, and Behavior: An Introduction to Theory and Research</source><publisher-loc>Reading, MA</publisher-loc><publisher-name>Addison Wesley</publisher-name><year>1975</year></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>WR</given-names></name><name><surname>Rollnick</surname><given-names>S</given-names></name></person-group><source>Motivational Interviewing: Preparing People for Change</source><publisher-loc>New York, NY</publisher-loc><publisher-name>Guilford Press</publisher-name><year>2013</year></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prochaska</surname><given-names>JO</given-names></name><name><surname>Velicer</surname><given-names>WF</given-names></name></person-group><article-title>The transtheoretical model of health behavior change</article-title><source>Am J Health Promot</source><year>1997</year><volume>12</volume><fpage>38</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">10170434</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wingood</surname><given-names>GM</given-names></name><name><surname>DiClemente</surname><given-names>RJ</given-names></name></person-group><article-title>The theory of gender and power: a social structural theory for guidng public health interventions</article-title><source>Emerging Theories in Health Promotion Practice and Research: Strategies for Improving Public Health</source><person-group person-group-type="editor"><name><surname>DiClemente</surname><given-names>RJ</given-names></name><name><surname>Crosby</surname><given-names>RA</given-names></name><name><surname>Kegler</surname><given-names>MC</given-names></name></person-group><year>2013</year><fpage>313</fpage><lpage>346</lpage></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metsch</surname><given-names>LR</given-names></name><name><surname>McCoy</surname><given-names>CB</given-names></name><name><surname>Lai</surname><given-names>S</given-names></name><name><surname>Miles</surname><given-names>C</given-names></name></person-group><article-title>Continuing risk behaviors among HIV-seropositive chronic drug users in Miami, Florida</article-title><source>AIDS and Behavior</source><year>1998</year><volume>2</volume><fpage>161</fpage><lpage>169</lpage></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>LI</given-names></name><name><surname>Marks</surname><given-names>G</given-names></name><name><surname>O&#x02019;Daniels</surname><given-names>CM</given-names></name><name><surname>Wilson</surname><given-names>TE</given-names></name><name><surname>Golin</surname><given-names>C</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><etal/></person-group><article-title>Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIV</article-title><source>AIDS Patient Care STDS</source><year>2008</year><volume>22</volume><fpage>627</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">18627280</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>JJ</given-names></name><name><surname>Shade</surname><given-names>SB</given-names></name><name><surname>Rose</surname><given-names>CD</given-names></name><name><surname>Koester</surname><given-names>K</given-names></name><name><surname>Maiorana</surname><given-names>A</given-names></name><name><surname>Malitz</surname><given-names>FE</given-names></name><etal/></person-group><article-title>Interventions delivered in clinical settings are effective in reducing risk of HIV transmission among people living with HIV: results from the Health Resources and Services Administration (HRSA)&#x02019;s Special Projects of National Significance initiative</article-title><source>AIDS Behav</source><year>2010</year><volume>14</volume><fpage>483</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">20229132</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="web"><collab>CDC</collab><source>Prevention IS Care</source><comment><ext-link ext-link-type="uri" xlink:href="http://wwwn.cdc.gov/pubs/PIC.aspx">http://wwwn.cdc.gov/pubs/PIC.aspx</ext-link></comment><date-in-citation>Accessed 15 April 2013</date-in-citation></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Margolis</surname><given-names>AD</given-names></name><name><surname>Wolitski</surname><given-names>RJ</given-names></name><name><surname>Parsons</surname><given-names>JT</given-names></name><name><surname>Gomez</surname><given-names>CA</given-names></name></person-group><article-title>Are healthcare providers talking to HIV-seropositive patients about safer sex?</article-title><source>AIDS</source><year>2001</year><volume>15</volume><fpage>2335</fpage><lpage>2337</lpage><pub-id pub-id-type="pmid">11698714</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname><given-names>G</given-names></name><name><surname>Richardson</surname><given-names>JL</given-names></name><name><surname>Crepaz</surname><given-names>N</given-names></name><name><surname>Stoyanoff</surname><given-names>S</given-names></name><name><surname>Milam</surname><given-names>J</given-names></name><name><surname>Kemper</surname><given-names>C</given-names></name><etal/></person-group><article-title>Are HIV care providers talking with patients about safer sex and disclosure?: A multi-clinic assessment</article-title><source>AIDS</source><year>2002</year><volume>16</volume><fpage>1953</fpage><lpage>1957</lpage><pub-id pub-id-type="pmid">12351956</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>JD</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Santibanez</surname><given-names>S</given-names></name><name><surname>Arnsten</surname><given-names>J</given-names></name><name><surname>Knowlton</surname><given-names>A</given-names></name><name><surname>Gomez</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Providers&#x02019; HIV prevention discussions with HIV-seropositive injection drug users</article-title><source>AIDS Behav</source><year>2006</year><volume>10</volume><fpage>699</fpage><lpage>705</lpage><pub-id pub-id-type="pmid">16639542</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>SF</given-names></name><name><surname>Koester</surname><given-names>KA</given-names></name><name><surname>Steward</surname><given-names>WT</given-names></name><name><surname>Maiorana</surname><given-names>A</given-names></name><name><surname>McLaughlin</surname><given-names>M</given-names></name><name><surname>Myers</surname><given-names>JJ</given-names></name><etal/></person-group><article-title>Missed opportunities: prevention with HIV-infected patients in clinical care settings</article-title><source>J Acquir Immune Defic Syndr</source><year>2004</year><volume>36</volume><fpage>960</fpage><lpage>966</lpage><pub-id pub-id-type="pmid">15220703</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metsch</surname><given-names>LR</given-names></name><name><surname>Pereyra</surname><given-names>M</given-names></name><name><surname>Del</surname><given-names>RC</given-names></name><name><surname>Gardner</surname><given-names>L</given-names></name><name><surname>Duffus</surname><given-names>WA</given-names></name><name><surname>Dickinson</surname><given-names>G</given-names></name><etal/></person-group><article-title>Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities</article-title><source>Am J Public Health</source><year>2004</year><volume>94</volume><fpage>1186</fpage><lpage>1192</lpage><pub-id pub-id-type="pmid">15226141</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>JJ</given-names></name><name><surname>Kang Dufour</surname><given-names>MS</given-names></name><name><surname>Koester</surname><given-names>KA</given-names></name><name><surname>Rose</surname><given-names>CD</given-names></name><name><surname>Shade</surname><given-names>SB</given-names></name><name><surname>Maiorana</surname><given-names>A</given-names></name><etal/></person-group><article-title>Helping clinicians deliver consistent HIV prevention counseling to their HIV-infected patients</article-title><source>AIDS Care</source><year>2013</year><volume>25</volume><fpage>640</fpage><lpage>645</lpage><pub-id pub-id-type="pmid">22970975</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bluespruce</surname><given-names>J</given-names></name><name><surname>Dodge</surname><given-names>WT</given-names></name><name><surname>Grothaus</surname><given-names>L</given-names></name><name><surname>Wheeler</surname><given-names>K</given-names></name><name><surname>Rebolledo</surname><given-names>V</given-names></name><name><surname>Carey</surname><given-names>JW</given-names></name><etal/></person-group><article-title>HIV prevention in primary care: impact of a clinical intervention</article-title><source>AIDS Patient Care STDS</source><year>2001</year><volume>15</volume><fpage>243</fpage><lpage>253</lpage><pub-id pub-id-type="pmid">11530765</pub-id></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardner</surname><given-names>LI</given-names></name><name><surname>Metsch</surname><given-names>L</given-names></name><name><surname>Strathdee</surname><given-names>SA</given-names></name><name><surname>Del</surname><given-names>RC</given-names></name><name><surname>Mahoney</surname><given-names>P</given-names></name><name><surname>Holmberg</surname><given-names>SD</given-names></name></person-group><article-title>Frequency of discussing HIV prevention and care topics with patients with HIV: influence of physician gender, race/ethnicity, and practice characteristics</article-title><source>Gend Med</source><year>2008</year><volume>5</volume><fpage>259</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">18727992</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>JJ</given-names></name><name><surname>Rose</surname><given-names>CD</given-names></name><name><surname>Shade</surname><given-names>SB</given-names></name><name><surname>Koester</surname><given-names>KA</given-names></name><name><surname>Maiorana</surname><given-names>A</given-names></name><name><surname>Malitz</surname><given-names>F</given-names></name><etal/></person-group><article-title>Sex, risk and responsibility: provider attitudes and beliefs predict HIV transmission risk prevention counseling in clinical care settings</article-title><source>AIDS Behav</source><year>2007</year><volume>11</volume><fpage>S30</fpage><lpage>S38</lpage><pub-id pub-id-type="pmid">17594138</pub-id></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steward</surname><given-names>WT</given-names></name><name><surname>Koester</surname><given-names>KA</given-names></name><name><surname>Myers</surname><given-names>JJ</given-names></name><name><surname>Morin</surname><given-names>SF</given-names></name></person-group><article-title>Provider fatalism reduces the likelihood of HIV-prevention counseling in primary care settings</article-title><source>AIDS Behav</source><year>2006</year><volume>10</volume><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">16323037</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thrun</surname><given-names>M</given-names></name><name><surname>Cook</surname><given-names>PF</given-names></name><name><surname>Bradley-Springer</surname><given-names>LA</given-names></name><name><surname>Gardner</surname><given-names>L</given-names></name><name><surname>Marks</surname><given-names>G</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><etal/></person-group><article-title>Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPs</article-title><source>AIDS Educ Prev</source><year>2009</year><volume>21</volume><fpage>55</fpage><lpage>66</lpage><pub-id pub-id-type="pmid">19243231</pub-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="web"><collab>CDC</collab><source>Risk screening and risk-reduction interventions</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/hiv/pwp/riskreduction.html">http://www.cdc.gov/hiv/pwp/riskreduction.html</ext-link></comment><date-in-citation>Accessed 15 February 2013</date-in-citation></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noar</surname><given-names>SM</given-names></name><name><surname>Black</surname><given-names>HG</given-names></name><name><surname>Pierce</surname><given-names>LB</given-names></name></person-group><article-title>Efficacy of computer technology-based HIV prevention interventions: a meta-analysis</article-title><source>AIDS</source><year>2009</year><volume>23</volume><fpage>107</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">19050392</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padian</surname><given-names>NS</given-names></name><name><surname>McCoy</surname><given-names>SI</given-names></name><name><surname>Balkus</surname><given-names>JE</given-names></name><name><surname>Wasserheit</surname><given-names>JN</given-names></name></person-group><article-title>Weighing the gold in the gold standard: challenges in HIV prevention research</article-title><source>AIDS</source><year>2010</year><volume>24</volume><fpage>621</fpage><lpage>635</lpage><pub-id pub-id-type="pmid">20179575</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinhardt</surname><given-names>LS</given-names></name><name><surname>Forsyth</surname><given-names>AD</given-names></name><name><surname>Carey</surname><given-names>MP</given-names></name><name><surname>Jaworski</surname><given-names>BC</given-names></name><name><surname>Durant</surname><given-names>LE</given-names></name></person-group><article-title>Reliability and validity of self-report measures of HIV-related sexual behavior: progress since 1990 and recommendations for research and practice</article-title><source>Arch Sex Behav</source><year>1998</year><volume>27</volume><fpage>155</fpage><lpage>180</lpage><pub-id pub-id-type="pmid">9562899</pub-id></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fishbein</surname><given-names>M</given-names></name><name><surname>Pequegnat</surname><given-names>W</given-names></name></person-group><article-title>Evaluating AIDS prevention interventions using behavioral and biological outcome measures</article-title><source>Sex Transm Dis</source><year>2000</year><volume>27</volume><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">10676977</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Flow chart of search</p></caption><graphic xlink:href="nihms724126f1"/></fig><table-wrap id="T1" position="float" orientation="landscape"><label>Table 1</label><caption><p>Descriptive Characteristics of 48 HIV Behavioral Interventions for People Living with HIV (PLWH)</p></caption><table frame="box" rules="all"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Category</th><th valign="bottom" align="left" rowspan="1" colspan="1">First Author [Citation Number], Study Years, Region</th><th valign="bottom" align="left" rowspan="1" colspan="1">HIV-positive Subpopulation (Baseline Sample Size)</th><th valign="bottom" align="left" rowspan="1" colspan="1">Study Design, Comparison Group</th><th valign="bottom" align="left" rowspan="1" colspan="1">Intervention Name (# of sessions/ total hours), Intervention Level</th><th valign="bottom" align="left" rowspan="1" colspan="1">Sex, Drug and Biological Outcomes</th></tr></thead><tbody><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">El-Bassel et al. [<xref rid="R36" ref-type="bibr">36</xref>], 2003&#x02013;2008, S, NE, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">African-American HIV serodiscordant heterosexual couples (1070)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Project EBAN (8/16), Couple</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold>: (1) higher mean proportion of condom-protected sex during anal or vaginal sex at 6 months after intervention: (RR=1.22, 95% CI: 1.05 to 1.41, p=.01); (2) consistent condom use during anal or vaginal sex at 6 months after intervention (RR=1.57, 95% CI: 1.27 to 1.94, p&#x0003c;.001) and at 12 months after intervention (RR=1.40, 95% CI: 1.13 to 1.75, p=.003); (3) lower log mean of unprotected anal or vaginal sex at 6 months after intervention (difference = &#x02212;1.79, 95% CI: &#x02212;2.50 to &#x02212;1.08, p&#x0003c;.001) and at 12 months after intervention (difference = &#x02212;1.15, 95% CI: &#x02212;1.88 to &#x02212;0.42, p=.002).<break/>No significant effect: the number of concurrent <bold>TRB</bold> partners at 6 months (RR=0.96, 95% CI=0.71 to 1.29, p=.95) and 12 months (RR=1.01, 95% CI = 0.78 to 1.30, p=.95) after intervention.<break/><break/><italic>Biologic outcome</italic><break/>No significant effect on the cumulative incidence of STDs (chlamydia, gonorrhea, or trichomonas) over the 12- month assessment period (RR=0.98, 95% CI; 0.62 to 1.56., p=.93).<break/><bold>The overall HIV seroconversion</bold> at the 12-month assessment was 5 (2 in the intervention group and 3 in the comparison group) &#x02013; analysis not powered to detect difference in HIV seroconversion.</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Fisher et al. [<xref rid="R37" ref-type="bibr">37</xref>], 2000&#x02013;2003, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">HIV clinic patients (497)</td><td align="left" valign="bottom" rowspan="1" colspan="1">Non-RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Options/Opcio nes (5&#x02013;10 minutes per clinic session), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold> and other outcomes across the 6-, 12-, and 18-month post-baseline assessments: (1) fewer unprotected anal or vaginal <bold>TRB</bold> (<italic>b</italic> = &#x02212;.28, <italic>se</italic> =.15, p=.05)<xref rid="TFN5" ref-type="table-fn">a</xref>; (2) fewer unprotected anal or vaginal sex acts with any partners (<italic>b</italic> = &#x02212;.38, <italic>se</italic> =.15, p=.012)<xref rid="TFN5" ref-type="table-fn">a</xref>.</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Gilbert et al. [<xref rid="R39" ref-type="bibr">39</xref>], 2003&#x02013;2006, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">HIV clinic patients (471)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Positive Choice: Interactive Video Doctor (2/0.75), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects: (1) less likely to report unprotected anal or vaginal sex at 3 months after the initial counseling session (RR=0.88, 95% CI = 0.773 to 0.993, p=.039) and at 3 months after the booster counseling (RR=0.80, 95% CI=0.686 to 0.941, p=.007); (2) fewer number of casual sex partners at 3 months after the booster counseling (&#x02212;2.7 vs. &#x02212; 0.6, p=.042).<break/>No significant effect on the absolute percent change in condom use with main partners or with casual partners at the 2 assessments (p&#x0003e;.05).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Golin et al. [<xref rid="R40" ref-type="bibr">40</xref>], 2006&#x02013;2009, S</td><td align="left" valign="bottom" rowspan="1" colspan="1">Sexually active adult clinic patients (490)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Motivational Interviewing (4/4) Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold>: greater reduction in unprotected anal or vaginal <bold>TRB</bold> at 4 months after intervention (<italic>b</italic>= &#x02212;1.86, <italic>se</italic>= 0.92, p=.04).<break/>No significant effect on the reduction in unprotected vaginal or anal sex acts with any partners at 4 months after intervention (<italic>b</italic>= &#x02212;0.71, <italic>se</italic>= 0.70, p=.32).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Kalichman et al. [<xref rid="R44" ref-type="bibr">44</xref>], 1997&#x02013;1998, S</td><td align="left" valign="bottom" rowspan="1" colspan="1">None (328)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Healthy Relationships (5/10), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold> and other outcomes: (1) fewer unprotected anal or vaginal <bold>TRB</bold> at 3 months (F=4.7, p=.03) and at 6 months (F=4.2, p=.04) after intervention; (2) fewer number of <bold>TRB</bold> partners at 6 months after intervention (OR=2.7, 95% CI NR, p=.04); (3) fewer unprotected anal or vaginal sex acts with any sex partners at 6 months after intervention (F=7.7, p=.01); (4) greater proportion of condom use during anal or vaginal sex with any partners at 6 months after intervention (F=3.8, p=.05).<break/>No significant effect on the proportion of condom use during anal or vaginal sex with non-HIV-positive partners at 3 months (p=.60) and 6 months (p=.23) after intervention.</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Kalichman et al.[<xref rid="R45" ref-type="bibr">45</xref>], 2005&#x02013;2009, S</td><td align="left" valign="bottom" rowspan="1" colspan="1">None (436)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Integrated Risk Reduction and Adherence Intervention (7/12), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold>: fewer <bold>TRB</bold> at 1.5 months after intervention (Mean=0.9 [SD=5.3] vs. Mean=2.3 [SD=15.0], p &#x0003c;.05) and at 4.5 months after intervention (Mean=0.2 [SD=1.0] vs. Mean=1.0 [SD=3.8], p&#x0003c;.05).<break/>No significant effect on the number of <bold>TRB</bold> sex partners over the assessment points (p=.1).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">McKirnan et al. [<xref rid="R54" ref-type="bibr">54</xref>], 2004&#x02013;2006, MW</td><td align="left" valign="bottom" rowspan="1" colspan="1">MSM (313)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Treatment Advocacy Program (4/9), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold>: (1) decrease in the percentage of participants reporting any <bold>TRB</bold> across the 12-month assessment period (&#x003c7;2 (2, N=249)=6.59, p=.037), from baseline to 4 months post-intervention (&#x003c7;2 (1, N=249)= 6.57, p=.01), and from baseline to the mean of 4 and 10 months post-intervention (&#x003c7;2 (1, N=249)=5.47, p=.019); (2) decrease in the mean number of <bold>TRB</bold> sex partners across the 12-month assessment period (&#x003c7;2 (2, N=249)=7.16, p = .008), from baseline to 4 months post-intervention (&#x003c7;2 (1, N=249)=7.01, p = .008), and from baseline to the mean of 4 and 10 months post-intervention (&#x003c7;2 (1, N=249)= 6.3, p=.012).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">NIMH et al. [<xref rid="R31" ref-type="bibr">31</xref>], 2000&#x02013;2004, NE, MW, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Engaged in HIV transmission risk behavior (936)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Waitlist</td><td align="left" valign="bottom" rowspan="1" colspan="1">Healthy Living Project (15/22.5), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold>: greater reduction in the mean number of unprotected anal or vaginal <bold>TRB</bold> from 5&#x02013;25 months post baseline (&#x003c7;2=27.8, df=5; p&#x0003c;.0001) and 20 months post baseline (8 months after intervention) (p=.0014).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Richardson et al. [<xref rid="R59" ref-type="bibr">59</xref>], 1998&#x02013;2001, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">HIV clinic patients (886)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Partnership for Health (3&#x02013;5 minutes each clinic visit), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects: less likely to report unprotected anal or vaginal sex at 1 to 7 months among those who had 2 or more sex partners at baseline (OR=0.42, 95% CI=0.19 to 0.91, p=.03), among men who have sex with men with 2 more sex partners at baseline (OR=0.43, 95% CI=0.19 to 0.94, p=.04), and among those who had any casual or exchange partners at baseline (OR=0.51, 95% CI=0.27 to 0.95, p=.04).<break/>No significant effect among those who had only main partners at baseline (OR=1.31, 95% CI=0.67, 2.57, p=.44)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Rotheram-Borus et al. [<xref rid="R62" ref-type="bibr">62</xref>], 1994&#x02013;1996, W, NE, S</td><td align="left" valign="bottom" rowspan="1" colspan="1">HIV+ youth (310)</td><td align="left" valign="bottom" rowspan="1" colspan="1">Non-RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Teens Linked to Care (31/62), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold> and other outcomes at 3 months after Act Safe intervention module: (1) lower mean percentage of unprotected anal or vaginal <bold>TRB</bold> (2.8% vs. 15.5%, p &#x0003c; .05); (2) more likely to report no sex or 100% condom use (80% vs. 67%, p&#x0003c;.01).<break/>No significant effect on the number of sex partners (0.2 vs. 0.2, p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Rotheram-Borus et al. [<xref rid="R63" ref-type="bibr">63</xref>], 1999&#x02013;2003, W, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">Young substance abusers (175)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Waitlist</td><td align="left" valign="bottom" rowspan="1" colspan="1">Choosing Life: Empowerment, Actions, Results (CLEAR) (18/36), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold> and other outcomes at 15 months post baseline: Increased proportion of protected acts with all sex partners (58% vs. 22%, p&#x0003c;.01) and with HIV-negative partners (73% vs. 32%, p &#x0003c;.01).<break/>No significant effect on 100% condom use or abstinent (58% vs. 59%, p value NR).<break/><italic>Drug outcome</italic><break/>No significant effect on the percentage of participants injected drugs (11% vs. 20%, p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Sikkema et al. [<xref rid="R67" ref-type="bibr">67</xref>], 2002&#x02013;2005, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">With childhood sexual abuse history (247)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">LIFT (15/22.5) Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold> and other outcomes across 4-, 8-, and 12-month assessments: fewer unprotected anal or vaginal sex acts with all partners (&#x003b2;=&#x02212;0.233; F(1,540)=131.61; p&#x0003c;.001)and with HIV-negative and unknown serostatus partners (&#x003b2;=&#x02212;0.315; F(1,221)=57.22; p&#x0003c;.001).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Wingood et al. [<xref rid="R74" ref-type="bibr">74</xref>], 1997&#x02013;2002, S</td><td align="left" valign="bottom" rowspan="1" colspan="1">Sexually active HIV+ female clinic patients (391)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">WILLOW (4/16), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects: (1) fewer unprotected vaginal sex acts at 6 months (mean difference= &#x02212;.05, p=.037) and at 12 months (mean difference= &#x02212;1.3, p=.029) after intervention; (2) less likely to report never using condoms at 6 months (OR=0.3, 95% CI=0.7 to 0.9), p=.043) and 12 months (OR=0.2, 95% CI=0.5 to 0.8, p=.026) after intervention.<break/><break/><italic>Biologic outcome</italic><break/>Significant positive intervention effect: less likely to acquire new bacterial STDs (chlamydia and gonorrhea) over the 12 month period (OR=0.2, 95% CI=0.1 to 0.6, p=.006).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Wolitski et al. [<xref rid="R75" ref-type="bibr">75</xref>], 2000&#x02013;2002, NE, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">MSM who engaged in HIV transmission risk behavior (811)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Summit Enhanced Peer- Led (6/18), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold>: less likely to report unprotected receptive anal <bold>TRB</bold> at 3 months after intervention (OR =0.65, 95% CI=0.44, 0.97, p&#x0003c;.05).<break/>No significant effect on unprotected insertive <bold>TRB</bold> (OR =0.74, 95% CI=0.48, 1.16).<break/><break/><italic>Biologic outcome</italic><break/>No significant effect: STDs (syphilis, gonorrhea, chlamydia, and herpes simplex virus 1 and 2) at 6 months after intervention (test results and p value NR)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Rigorous Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Holstad et al. [<xref rid="R42" ref-type="bibr">42</xref>], 2005&#x02013;2008, S</td><td align="left" valign="bottom" rowspan="1" colspan="1">Women (203)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Group Motivational Interviewing (8/16), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects: (1) abstinence, (2) use of condom during anal, oral, or vaginal sex during the assessment periods (baseline, 2 weeks, 3 months, 6 months, and 9 months)(test results and p values NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Rigorous Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Illa et al. [<xref rid="R43" ref-type="bibr">43</xref>], 2004&#x02013;2007, S</td><td align="left" valign="bottom" rowspan="1" colspan="1">Sexually active older clinic patients (241)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Project ROADMAP (4/6), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects on <bold>TRB</bold> and other outcomes: inconsistent condom use at 6 months post baseline with the following type of partners: (1) any sex partners (7% vs. 8%, p value NR); (2) <bold>TRB</bold> partners (1.3% vs. 3%, p value NR); (3) HIV-positive partners (5% vs. 6.5%, p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Rigorous Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Metsch et al. [<xref rid="R55" ref-type="bibr">55</xref>], 2001&#x02013;2003, S, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Recently diagnosed (316)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">ARTAS - Antiretroviral Treatment Access Study (5/NR), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects on TRB: unprotected anal or vaginal <bold>TRB</bold> over 12 months (OR=0.96, 95% CI=0.62 to 1.50, p=.865).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Rigorous Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Purcell et al. [<xref rid="R58" ref-type="bibr">58</xref>], 2001&#x02013;2004, NE, S, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Injection drug users (966)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">INSPIRE (10/20), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects on <bold>TRB:</bold> unprotected anal or vaginal <bold>TRB</bold> at (1) 3 months after intervention (OR=1.22, 95% CI=0.79, 1.89); (2) 6 months after intervention (OR=1.32, 95% CI=0.83, 2.12); (2)12 months after intervention (OR=1.01, 95% CI=0.63, 1.61).<break/><break/><italic>Drug outcome</italic><break/>No significant effects on lending a needle or sharing drug paraphernalia with HIV-negative or serostatus unknown partners at (1) 3 months after intervention (OR=0.78, 95% CI=0.49, 1.25); (2) 6 months after intervention (OR=0.68, 95% CI=0.40, 1.13); (2)12 months after intervention (OR=0.77, 95% CI=0.42, 1.41).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Rigorous Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Safren et al. [<xref rid="R64" ref-type="bibr">64</xref>], 2004&#x02013;2008, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">MSM who engaged in HIV transmission risk behavior (201)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Project Enhance (5/7.5 plus 4 boosters), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects on <bold>TRB</bold>: unprotected insertive or receptive anal <bold>TRB</bold> over time (baseline, 3, 6, 9 and 12 months)(OR=0.94, 95% CI=0.78 to 1.16).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Rigorous Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Sorensen et al. [<xref rid="R69" ref-type="bibr">69</xref>], 1994&#x02013;1998, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Out of treatment substance abusers (190)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Case Management (ongoing), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effect on sex risk behaviors at 6 months after intervention (OR=0.97, 95% CI=0.54 to 1.74)<xref rid="TFN6" ref-type="table-fn">b</xref>.<break/><break/><italic>Drug outcome</italic><break/>No significant effect on needle-sharing behavior at 6 months after intervention (OR=0.63, 95% CI=0.35 to 1.13)<xref rid="TFN6" ref-type="table-fn">b</xref>.</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Rigorous Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Rosser et al. [<xref rid="R61" ref-type="bibr">61</xref>], 2005&#x02013;2007, NE, S, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">MSM who engaged in HIV transmission risk behavior (675)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Positive Connections (1/16), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects on <bold>TRB</bold>: unprotected anal <bold>TRB</bold>, condition by time (baseline, 6, 12, and 18 months after intervention)(test results and p values NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Rigorous Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Velasquez et al. [<xref rid="R71" ref-type="bibr">71</xref>], 1999&#x02013;2003, NR</td><td align="left" valign="bottom" rowspan="1" colspan="1">MSM with alcohol abuse (253)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Motivational Interviewing (8/NR), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects on the number of unprotected-sex days from baseline to 12 months (&#x003c7;2=2.92, df=8; p=.94)<xref rid="TFN5" ref-type="table-fn">a</xref>.</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Rigorous Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Williams et al. [<xref rid="R73" ref-type="bibr">73</xref>], NR, NR</td><td align="left" valign="bottom" rowspan="1" colspan="1">Heterosexual African American crack smokers (347)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Positive Choices (6/6), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects on consistent condom use during vaginal sex, condition by time (baseline, 3 and 9 months)(F=0.61, df NR, p=.43).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Rigorous Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Wolitski et al. [<xref rid="R76" ref-type="bibr">76</xref>], 2004&#x02013;2007, MW, S, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Homeless or at severe risk of homelessness (644)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Housing Assistance &#x00026; HIV Prevention (case management + 2 HIV sessions/1.25), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects on <bold>TRB</bold> and other outcomes: (1) unprotected anal or vaginal <bold>TRB,</bold> condition by time (baseline, 6, 12, and 18 months)(F=0.28, df NR, p=.84), (2) the number of partners, condition by time (baseline, 6, 12, and 18 months)(F=1.01, df NR, p=.39).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Chen et al. [<xref rid="R30" ref-type="bibr">30</xref>], 2005&#x02013;2007, MW, NE, S, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Youth with medication adherence, substance abuse or sexual risk problems (142)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Healthy Choices (4/6), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects from baseline to 15-month assessment: (1) increased odds of persistent low sex risk (0&#x02013;2 times no condom use during study period, OR=2.71, 95% CI=1.33 to 5.52, p &#x0003c;.01); (2) reduced odds of high sex risk (10 or more times no condom use during study period, OR=0.41, 95% CI=0.17 to 0.99, p&#x0003c;.05).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Coates et al. [<xref rid="R33" ref-type="bibr">33</xref>], NR, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Gay men (64)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Waitlist</td><td align="left" valign="bottom" rowspan="1" colspan="1">Stress Reduction Training (9/NR), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effect on the number of sex partners at post intervention (mean difference=1.20, 95%CI=0.14 to 2.28, p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Cosio et al. [<xref rid="R35" ref-type="bibr">35</xref>], 2007&#x02013;2008, MW, NE, S, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Rural &#x00026; engaged in HIV transmission risk behavior (79)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Telephone Motivational Interviewing (2/NR), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effect on the mean percentage of vaginal sex partners with whom condoms were used all the time at 2 months after intervention (27.1% vs. 22.5%, F=(1,77)=3.2, p&#x0003c;.05).<break/>No significant effect on the mean percentage of anal sex partners with whom condoms were used all the time at 2 months after intervention (20.1% vs. 19.4%, F value NR, p=.35).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Grinstead et al. [<xref rid="R41" ref-type="bibr">41</xref>], 1996&#x02013;1998, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Male prison inmates (123)</td><td align="left" valign="bottom" rowspan="1" colspan="1">Non-RCT, Waitlist</td><td align="left" valign="bottom" rowspan="1" colspan="1">Health Promotion (8/20), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effect on the percentage condom use at first sex since release (OR, 0.57; 95% CI, 0.18&#x02013;1.80)<xref rid="TFN6" ref-type="table-fn">b</xref>.<break/><break/><italic>Drug outcome</italic><break/>Significant positive intervention effect: Among injectors, less likely to report needle sharing at post-release (OR=0.11; 95% CI=0.03 to 0.41)<xref rid="TFN6" ref-type="table-fn">b</xref>.<break/>No significant effect on the percentage of participants injected drugs since release (48% vs. 48%, p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Lightfoot et al. [<xref rid="R48" ref-type="bibr">48</xref>], 2001&#x02013;2006, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">HIV clinic patients (529)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Waitlist</td><td align="left" valign="bottom" rowspan="1" colspan="1">MD4 LIFE computer- delivered (11/2), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects on <bold>TRB</bold> over the 30-month post baseline period: (1) decreased the number of <bold>TRB</bold> partners (t=2.34, df=1952, P= 0.02); (2) decreased the number of unprotected anal or vaginal <bold>TRB</bold> (t= 3.23, P&#x0003c; 0.01).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Lovejoy et al. [<xref rid="R49" ref-type="bibr">49</xref>], 2009&#x02013;2010, NE, MW, S</td><td align="left" valign="bottom" rowspan="1" colspan="1">Older adults who engaged in HIV transmission risk behavior (100)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Telephone- delivered Motivational Interviewing (4/3), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects: the fewer number of unprotected anal or vaginal sex at 3 months (OR=0.32, 95% CI=0.17 to 0.56)<xref rid="TFN6" ref-type="table-fn">b</xref> and 6 months (OR=0.37, 95% CI=0.2 to 0.69)<xref rid="TFN6" ref-type="table-fn">b</xref> after intervention.</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Margolin et al. [<xref rid="R50" ref-type="bibr">50</xref>], 1997&#x02013;2001, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">Injection drug users in methadone maintenance treatment (90)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">HHRP+ (48/minimum of 96), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex and drug outcomes</italic><break/>Significant positive intervention effect: less likely to engage in either unprotected sex or needle sharing or needle sharing 3 months after intervention (OR=2.96, 95% CI=1.05 to 8.36, p&#x0003c;.04).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Mausbach et al. [<xref rid="R52" ref-type="bibr">52</xref>], 1999&#x02013;2005, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Meth-using MSM who engaged in HIV transmission risk behavior (341)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">EDGE (8/12), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects: a greater (log) number of anal, oral and vaginal sex protected by a condom or oral dam at 5 months after intervention/8 months post baseline (t=2.13, df=283, p=.034) and at 9 months after intervention/12 months post baseline (t=2.72, df=480, p=.007).<break/>No significant effects: (1) (log) number of unprotected anal, oral, or vaginal sex (test results and p value NR); (2) ratio of total protected-to-total sex acts (test results and p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">McCoy et al. [<xref rid="R53" ref-type="bibr">53</xref>], 1990&#x02013;1992, S</td><td align="left" valign="bottom" rowspan="1" colspan="1">Injection drug users (140)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Case Management Services (on- going), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effect on the number of sex partner (multiple R=.15, p value NR) and use of condoms (multiple R=.38, p value NR) at 6 months after baseline.<break/><break/><italic>Drug outcome</italic><break/>Significant intervention effect on the number of injecting partners at 6 months after baseline (multiple R=.62, p&#x0003c;.01)<break/>No significant effect on injecting heroin and cocaine at 6 months after baseline (multiple R=.40, p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Petry et al. [<xref rid="R57" ref-type="bibr">57</xref>], 2003&#x02013;2008, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">Patients with cocaine or opioid use disorders (170)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Contingency Management (24/24), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex and drug outcomes</italic><break/>Significant positive intervention effects: reduced scores on the HIV Risk Behavior Scale, including risky sex and drug use behaviors, between baseline and 6 months (F(1,133)=4.75, p&#x0003c;.05) and baseline and 12 months (F(1,139)=5.23, p&#x0003c;.05).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Rose et al. [<xref rid="R59" ref-type="bibr">59</xref>], 2004&#x02013;2006, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">HIV clinic patients who engaged in HIV transmission risk behavior(386)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">HIV Intervention for Provider (ongoing), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects: reduced the number of sex partners (OR=0.49, 95% CI=0.26 to 0.92, p&#x0003c;.03) at 6 months post baseline.<break/>No significant effects on <bold>TRB</bold>: (1) the number of <bold>TRB</bold> partners (OR=0.93, 95% CI=0.82, 1.69, p=.86); (2) unprotected anal or vaginal <bold>TRB</bold> (OR=1.44, 95% CI=0.90 to 2.30, p=.42).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Teti et al. [<xref rid="R70" ref-type="bibr">70</xref>], 2004&#x02013;2008, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">Women (184)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Protect and Respect (5/7.5), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects: (1) greater odds of reporting condom use during anal or vaginal sex at 6 months (OR=17.13, 95% CI=2.96, 99.10, p&#x0003c;.01) and at 18 months (OR=270.04, 95% CI=24.53 to 2971.94, p&#x0003c;.01) post baseline.</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Positive Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Wyatt et al. [<xref rid="R77" ref-type="bibr">77</xref>], NR, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Women with histories of childhood sexual abuse (147)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Enhance Sexual Health Intervention (11/1.5), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant positive intervention effects: greater percentage of participants reporting vaginal sex protected by condom (OR=2.96, 95% CI NR, p=.039, one-tailed).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Cleary et al. [<xref rid="R32" ref-type="bibr">32</xref>], 1986&#x02013;1989, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">Recently diagnosed blood donors (271)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Cognitive Behavioral and Skills Training Support Group (6/9), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effect on the percentage of participants reporting unprotected sex at 10.5 months after intervention (30.9% vs. 37.7%, p value NR)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Coleman et al. [<xref rid="R34" ref-type="bibr">34</xref>], 2006&#x02013;2007, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">Older African American MSM (60)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Social Cognitive (4/8), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects at 3 months after intervention: (1) reported consistent condom use (OR=2.04, 95% CI=0.48 to 8.77, p=.336); (2) had multiple sex partners (OR=1.43, 95% CI=0.35 to 5.79, p=.062).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Fogarty et al. [<xref rid="R38" ref-type="bibr">38</xref>], 1993&#x02013;1996, S</td><td align="left" valign="bottom" rowspan="1" colspan="1">Women (322)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Women and Infants Demonstration Project (1&#x02013; 24/NR), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects: (1) the odds of progressing in use of condoms with main male partner at 6&#x02013;12 months (OR=1.95, p=.19) and at 12&#x02013;18 months (OR=2.13, p=.13) post baseline; (2) the odds of relapsing in use of condoms with main male partner at 6&#x02013;12 months (OR=0.38, p=.10) and at 12&#x02013;18 months (OR=0.47, p=.15) post baseline.</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Kelly et al. [<xref rid="R46" ref-type="bibr">46</xref>], 1991, MW</td><td align="left" valign="bottom" rowspan="1" colspan="1">Depressed Men (115)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Support Group (8/12), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effect on the mean number of unprotected insertive anal sex acts at 3 months after intervention (OR=0.92; 95% CI= 0.35 to 2.45, p value NR)<xref rid="TFN6" ref-type="table-fn">b</xref>.</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Lapinski et al. [<xref rid="R47" ref-type="bibr">47</xref>], NR, MW</td><td align="left" valign="bottom" rowspan="1" colspan="1">MSM (72)</td><td align="left" valign="bottom" rowspan="1" colspan="1">Non-RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Prevention Options for Positives (6/9), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effect on the mean score of risk reduction index at 6 weeks after intervention (1.45 vs. 1.23, p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Margolin et al. [<xref rid="R51" ref-type="bibr">51</xref>], NR, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">Injection drug users in methadone maintenance treatment (38)</td><td align="left" valign="bottom" rowspan="1" colspan="1">Non-RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">3-S+ for HIV+ drug users (12/NR), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex and drug outcomes</italic><break/>No significant effect on the mean score of the Risk Assessment Battery assessing a range of drug- and sex-related HIV risk behaviors after intervention (0.03 vs. 0.03, p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Patterson et al. [<xref rid="R56" ref-type="bibr">56</xref>], 1996&#x02013;2001, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">Engaged in HIV transmission risk behavior (387)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Share Safer Sex (3/4.5), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Significant <underline>negative</underline> intervention effect on <bold>TRB</bold> at 8 months after intervention: intervention group reporting more unprotected anal, oral, and vaginal <bold>TRB</bold> (test result and p value NR).<break/>No significant effect on <bold>TRB</bold> at 12 months after intervention: the mean number of unprotected anal, oral, and vaginal <bold>TRB</bold> (OR=0.66; 95% CI=0.33 to1.33)<xref rid="TFN6" ref-type="table-fn">b</xref>.<break/><break/><italic>Biologic outcome</italic><break/>No significant effect on the mean number of STDs (not defined) across 12 months after intervention (test results and p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Schwarcz et al. [<xref rid="R65" ref-type="bibr">65</xref>], 2006&#x02013;2010, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">MSM engaged in HIV transmission risk behavior (411)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, HIV demand control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Personalized Cognitive Counseling (2/2), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effect on <bold>TRB</bold>: (1) mean number of unprotected anal <bold>TRB</bold> at the 12-month assessment (6 months after intervention; incident rate ratio: 0.48, 95%CI=0.12, 1.84, p=.34), (2) percentage of participants reporting unprotected anal <bold>TRB</bold> at 6 months after intervention (27.8% vs. 22.3%, p value NR).<break/><break/><italic>Biologic outcome</italic><break/>No significant effect on the lab confirmed diagnosis of STD (gonorrhea or Chlamydia; test results and p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Serovich et al. [<xref rid="R66" ref-type="bibr">66</xref>], 2005&#x02013;2006, MW</td><td align="left" valign="bottom" rowspan="1" colspan="1">MSM (77)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Waitlist</td><td align="left" valign="bottom" rowspan="1" colspan="1">HIV-related Disclosure (4/5), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>Statistically significant <underline>negative</underline> intervention effect: intervention group had a greater odds of unprotected insertive anal sex at 3 months after intervention (OR=2.54, 95%CI NR, p&#x0003c;.05).<break/>No significant effect on the odds of unprotected receptive anal sex at 2 months after intervention (OR=1.55, 95% CI and p value NR).</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Sikkema et al. [<xref rid="R68" ref-type="bibr">68</xref>], 2006&#x02013;2008, NE</td><td align="left" valign="bottom" rowspan="1" colspan="1">Newly diagnosed bisexual/gay men in care (65)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Standard of care</td><td align="left" valign="bottom" rowspan="1" colspan="1">Positive Choices (3/3), Individual</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects at 3 months after intervention/6 months post baseline: (1) unprotected anal or vaginal sex acts with any partners (OR=0.54, 95% CI=0.21 to 1.38)<xref rid="TFN6" ref-type="table-fn">b</xref>; (2) the number of sex partners (OR=0.72, 95% CI=0.28 to 1.82)<xref rid="TFN6" ref-type="table-fn">b</xref>.<break/><break/><italic>Biologic outcome</italic><break/>No significant effect on STDs symptoms (not defined) at 3 months after intervention (24.1% vs. 28.6%, p value NR)</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1"><bold>Other Non-EBI</bold></td><td align="left" valign="bottom" rowspan="1" colspan="1">Williams et al. [<xref rid="R72" ref-type="bibr">72</xref>], 2003&#x02013;2006, W</td><td align="left" valign="bottom" rowspan="1" colspan="1">African American, Latino MSM (137)</td><td align="left" valign="bottom" rowspan="1" colspan="1">RCT, Attention control</td><td align="left" valign="bottom" rowspan="1" colspan="1">Sexual Health Intervention for Men (S- HIM) (6/12), Group</td><td align="left" valign="bottom" rowspan="1" colspan="1"><italic>Sex outcome</italic><break/>No significant effects: (1) the score of sex risk behavior scale, including oral, anal or vaginal sex (F (3, 130)=1.15, p=.33, condition by time interaction), (2) the number of sex partners (F(3, 129)&#x0003c;1, p value NR, condition by time interaction).</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>Category: EBI = evidence-based interventions that show at least one significant positive intervention effect and have low risk of bias in study design, implementation and analysis; Rigorous Non-EBI = interventions show no significant positive intervention effects but have low risk of bias; Positive non-EBI = interventions show at least one significant positive intervention effect but have high risk of bias; Other non-EBI = interventions show no significant positive intervention effect and have high risk of bias</p></fn><fn id="TFN2"><p>Region: NE=northeast, MW=midwest, S=south, W=west</p></fn><fn id="TFN3"><p>NR=not reported</p></fn><fn id="TFN4"><p>TRB = HIV <underline>t</underline>ransmission <underline>r</underline>isk <underline>b</underline>ehavior defined as unprotected sex with HIV-negative or serostatus unknown partners</p></fn><fn id="TFN5"><label>a</label><p>additional info obtained from authors;</p></fn><fn id="TFN6"><label>b</label><p>OR calculated based on descriptive data reported or provided by author</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float" orientation="landscape"><label>Table 2</label><caption><p>Percents and Medians of Select Characteristics of Evidence-Based Interventions (EBIs) and Non-EBIs</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">All Interventions</th><th valign="bottom" align="center" rowspan="1" colspan="1">EBIs</th><th valign="bottom" align="center" rowspan="1" colspan="1">Non-EBIs</th><th colspan="3" valign="bottom" align="center" rowspan="1">Non-EBIs by Type
<hr/></th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1"><italic>Rigorous</italic></th><th valign="bottom" align="center" rowspan="1" colspan="1"><italic>Positive</italic>
<hr/></th><th valign="bottom" align="center" rowspan="1" colspan="1"><italic>Other</italic></th></tr><tr><th valign="bottom" align="left" rowspan="1" colspan="1"/><th valign="bottom" align="center" rowspan="1" colspan="1">k (%)</th><th valign="bottom" align="center" rowspan="1" colspan="1">k (%)</th><th valign="bottom" align="center" rowspan="1" colspan="1">k (%)</th><th valign="bottom" align="center" rowspan="1" colspan="1">k (%)</th><th valign="bottom" align="center" rowspan="1" colspan="1">k (%)</th><th valign="bottom" align="center" rowspan="1" colspan="1">k (%)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Total (% of total)</bold></td><td align="center" valign="top" rowspan="1" colspan="1">48</td><td align="center" valign="top" rowspan="1" colspan="1">14 (29%)</td><td align="center" valign="top" rowspan="1" colspan="1">34 (71%)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (21%)</td><td align="center" valign="top" rowspan="1" colspan="1">13 (27%)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (23%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Conducted</bold></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Pre-ART (1988 to 1995)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (13%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (18%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (15%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (27%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Early-ART (1996&#x02013;2003)</td><td align="center" valign="top" rowspan="1" colspan="1">24 (50%)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (79%)<xref rid="TFN12" ref-type="table-fn">a</xref>,<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">13 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (30%)<xref rid="TFN12" ref-type="table-fn">a</xref></td><td align="center" valign="top" rowspan="1" colspan="1">6 (46%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">4 (36%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Later-ART (2004&#x02013;2012)</td><td align="center" valign="top" rowspan="1" colspan="1">18 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (21%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">15 (44%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (60%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (36%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>&#x0003e;1 Study Site</bold></td><td align="center" valign="top" rowspan="1" colspan="1">20 (42%)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (71%)<xref rid="TFN13" ref-type="table-fn">b</xref>,<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">10 (29%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (50%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (38%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>No Significant Positive Findings</bold></td><td align="center" valign="top" rowspan="1" colspan="1">21 (44%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)<xref rid="TFN12" ref-type="table-fn">a</xref></td><td align="center" valign="top" rowspan="1" colspan="1">21 (62%)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (100%)<xref rid="TFN12" ref-type="table-fn">a</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (100%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Sources of Bias</bold></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Small sample size</td><td align="center" valign="top" rowspan="1" colspan="1">16 (33%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)<xref rid="TFN14" ref-type="table-fn">c</xref></td><td align="center" valign="top" rowspan="1" colspan="1">16 (47%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (62%)<xref rid="TFN14" ref-type="table-fn">c</xref></td><td align="center" valign="top" rowspan="1" colspan="1">8 (73%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Retention</td><td align="center" valign="top" rowspan="1" colspan="1">9 (19%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)<xref rid="TFN14" ref-type="table-fn">c</xref></td><td align="center" valign="top" rowspan="1" colspan="1">9 (26%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (31%)<xref rid="TFN14" ref-type="table-fn">c</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (45%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Differential attrition</td><td align="center" valign="top" rowspan="1" colspan="1">8 (17%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">8 (24%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (23%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (45%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other limitations (missing data, etc)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (15%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)<xref rid="TFN14" ref-type="table-fn">c</xref></td><td align="center" valign="top" rowspan="1" colspan="1">7 (21%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (38%)<xref rid="TFN14" ref-type="table-fn">c</xref></td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Follow-up</td><td align="center" valign="top" rowspan="1" colspan="1">5 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)<xref rid="TFN14" ref-type="table-fn">c</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (15%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (31%)<xref rid="TFN14" ref-type="table-fn">c</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1 (9%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Allocation method</td><td align="center" valign="top" rowspan="1" colspan="1">2 (4%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (6%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Intent-to-Treat analysis</td><td align="center" valign="top" rowspan="1" colspan="1">2 (4%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (6%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Negative intervention effect</td><td align="center" valign="top" rowspan="1" colspan="1">2 (4%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (6%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Target Groups</bold><xref rid="TFN16" ref-type="table-fn">&#x003b1;</xref></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Clinic patients</td><td align="center" valign="top" rowspan="1" colspan="1">17 (35%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (50%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">10 (29%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (30%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;MSM</td><td align="center" valign="top" rowspan="1" colspan="1">13 (27%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (14%)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (32%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (30%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (15%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (55%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Engaged in HIV transmission risk<xref rid="TFN17" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">11 (23%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (21%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (24%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (20%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (31%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Substance use</td><td align="center" valign="top" rowspan="1" colspan="1">10 (21%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (7%)<xref rid="TFN13" ref-type="table-fn">b</xref>,<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">9 (26%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (40%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">4 (31%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1 (9%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Female</td><td align="center" valign="top" rowspan="1" colspan="1">5 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (7%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (12%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (15%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (9%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;African American</td><td align="center" valign="top" rowspan="1" colspan="1">4 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (7%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Depressed or childhood abuse</td><td align="center" valign="top" rowspan="1" colspan="1">4 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (7%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (9%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Younger age (13 to 25 years)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (6%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (14%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Older age group (&#x0003e;45 years)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (6%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (9%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Newly diagnosed</td><td align="center" valign="top" rowspan="1" colspan="1">3 (6%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Substance using MSM</td><td align="center" valign="top" rowspan="1" colspan="1">2 (4%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (9%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Male prison inmate</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Homeless</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Rural residents</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Sample Characteristics (median)</bold><xref rid="TFN16" ref-type="table-fn">&#x003b1;</xref></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Black</td><td align="center" valign="top" rowspan="1" colspan="1">50%</td><td align="center" valign="top" rowspan="1" colspan="1">48%</td><td align="center" valign="top" rowspan="1" colspan="1">54%</td><td align="center" valign="top" rowspan="1" colspan="1">63%</td><td align="center" valign="top" rowspan="1" colspan="1">51%</td><td align="center" valign="top" rowspan="1" colspan="1">37%</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Latino</td><td align="center" valign="top" rowspan="1" colspan="1">15%</td><td align="center" valign="top" rowspan="1" colspan="1">17%</td><td align="center" valign="top" rowspan="1" colspan="1">13%</td><td align="center" valign="top" rowspan="1" colspan="1">12%</td><td align="center" valign="top" rowspan="1" colspan="1">14%</td><td align="center" valign="top" rowspan="1" colspan="1">13%</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;White</td><td align="center" valign="top" rowspan="1" colspan="1">23%</td><td align="center" valign="top" rowspan="1" colspan="1">22%</td><td align="center" valign="top" rowspan="1" colspan="1">32%</td><td align="center" valign="top" rowspan="1" colspan="1">9%</td><td align="center" valign="top" rowspan="1" colspan="1">23%</td><td align="center" valign="top" rowspan="1" colspan="1">49%</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Male</td><td align="center" valign="top" rowspan="1" colspan="1">72%</td><td align="center" valign="top" rowspan="1" colspan="1">71%</td><td align="center" valign="top" rowspan="1" colspan="1">78%</td><td align="center" valign="top" rowspan="1" colspan="1">70%</td><td align="center" valign="top" rowspan="1" colspan="1">70%</td><td align="center" valign="top" rowspan="1" colspan="1">100%</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Female</td><td align="center" valign="top" rowspan="1" colspan="1">27%</td><td align="center" valign="top" rowspan="1" colspan="1">28%</td><td align="center" valign="top" rowspan="1" colspan="1">27%</td><td align="center" valign="top" rowspan="1" colspan="1">29%</td><td align="center" valign="top" rowspan="1" colspan="1">37%</td><td align="center" valign="top" rowspan="1" colspan="1">36%</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Average age (years)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">42</td><td align="center" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">42</td><td align="center" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">39</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Comparison group</bold></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Standard of care or Waitlist</td><td align="center" valign="top" rowspan="1" colspan="1">20 (42%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (43%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">14 (41%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (20%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">7 (54%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (45%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Non-HIV Attention control<xref rid="TFN18" ref-type="table-fn">&#x003d5;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">12 (25%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (43%)<xref rid="TFN13" ref-type="table-fn">b</xref>,<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">6 (18%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">2 (15%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">3 (27%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;HIV Demand control<xref rid="TFN19" ref-type="table-fn">&#x0023a;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">16 (33%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (14%)<xref rid="TFN12" ref-type="table-fn">a</xref></td><td align="center" valign="top" rowspan="1" colspan="1">14 (41%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (70%)<xref rid="TFN12" ref-type="table-fn">a</xref></td><td align="center" valign="top" rowspan="1" colspan="1">4 (31%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (27%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Power analysis reported</bold></td><td align="center" valign="top" rowspan="1" colspan="1">20 (42%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (57%)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (35%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (50%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Used ACASI for Data Collection</bold></td><td align="center" valign="top" rowspan="1" colspan="1">20 (42%)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (64%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">11 (32%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (60%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (23%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"><bold>Theory reported</bold></td><td align="center" valign="top" rowspan="1" colspan="1">42 (88%)</td><td align="center" valign="top" rowspan="1" colspan="1">14 (100%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">28 (82%)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (90%)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (77%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">9 (82%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Intervention Setting</bold><xref rid="TFN16" ref-type="table-fn">&#x003b1;</xref></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Health Care<xref rid="TFN20" ref-type="table-fn">&#x003b2;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">24 (50%)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (71%)<xref rid="TFN13" ref-type="table-fn">b</xref>,<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">14 (41%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (50%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (38%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">4 (36%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Community based establishment<xref rid="TFN21" ref-type="table-fn">&#x02260;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">11 (23%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (36%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (18%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (20%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (27%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Public area<xref rid="TFN22" ref-type="table-fn">^</xref></td><td align="center" valign="top" rowspan="1" colspan="1">4 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (14%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (6%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (15)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Commerical<xref rid="TFN23" ref-type="table-fn">+</xref></td><td align="center" valign="top" rowspan="1" colspan="1">2 (4%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (7%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (9%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Intervention Level</bold></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Individual</td><td align="center" valign="top" rowspan="1" colspan="1">21 (44%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (50%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">14 (41%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (30%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">7 (54%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (36%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Group</td><td align="center" valign="top" rowspan="1" colspan="1">26 (54%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (43%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">20 (59%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (70%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">6 (46%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (64%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Couple</td><td align="center" valign="top" rowspan="1" colspan="1">1 (2%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (7%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Deliverer</bold><xref rid="TFN16" ref-type="table-fn">&#x003b1;</xref><xref rid="TFN27" ref-type="table-fn">&#x000b6;</xref></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Professional<xref rid="TFN24" ref-type="table-fn">&#x000b1;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">28 (58%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (50%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">21 (62%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (40%)</td><td align="center" valign="top" rowspan="1" colspan="1">10 (77%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">8 (73%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Counselor or health educator</td><td align="center" valign="top" rowspan="1" colspan="1">19 (40%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (29%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">15 (44%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (30%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (62%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">6 (55%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02003;Healthcare worker</td><td align="center" valign="top" rowspan="1" colspan="1">9 (19%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (21%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (18%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (23%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Peer</td><td align="center" valign="top" rowspan="1" colspan="1">13 (27%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (29%)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (26%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (30%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (23%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (27%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Computer-based</td><td align="center" valign="top" rowspan="1" colspan="1">2 (4%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (7%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (3%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Intervention components</bold><xref rid="TFN16" ref-type="table-fn">&#x003b1;</xref></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Skills building</td><td align="center" valign="top" rowspan="1" colspan="1">32 (67%)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (64%)</td><td align="center" valign="top" rowspan="1" colspan="1">23 (68%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (60%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (62%)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (82%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;HIV risk reduction<xref rid="TFN25" ref-type="table-fn">&#x000f7;</xref>
<sup>4</sup></td><td align="center" valign="top" rowspan="1" colspan="1">31 (65%)</td><td align="center" valign="top" rowspan="1" colspan="1">12 (86%)<xref rid="TFN12" ref-type="table-fn">a</xref>,<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">19 (56%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (40%)<xref rid="TFN12" ref-type="table-fn">a</xref></td><td align="center" valign="top" rowspan="1" colspan="1">8 (62%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">7 (64%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Motivation</td><td align="center" valign="top" rowspan="1" colspan="1">29 (60%)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (79%)<xref rid="TFN13" ref-type="table-fn">b</xref>,<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">18 (53%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (50%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">6 (46%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">7 (64%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Self-efficacy</td><td align="center" valign="top" rowspan="1" colspan="1">27 (56%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (57%)</td><td align="center" valign="top" rowspan="1" colspan="1">19 (56%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (60%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (54%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (55%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Serostatus disclosure</td><td align="center" valign="top" rowspan="1" colspan="1">23 (48%)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (64%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">14 (41%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (50%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (31%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (45%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Social support</td><td align="center" valign="top" rowspan="1" colspan="1">21 (44%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (57%)</td><td align="center" valign="top" rowspan="1" colspan="1">13 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (40%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (36%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Personalized risk reduction plan</td><td align="center" valign="top" rowspan="1" colspan="1">21 (44%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (57%)</td><td align="center" valign="top" rowspan="1" colspan="1">13 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (40%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (46%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (27%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Misperception about HIV</td><td align="center" valign="top" rowspan="1" colspan="1">16 (33%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (57%)<xref rid="TFN13" ref-type="table-fn">b</xref>,<xref rid="TFN14" ref-type="table-fn">c</xref></td><td align="center" valign="top" rowspan="1" colspan="1">8 (24%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (30%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">2 (15%)<xref rid="TFN14" ref-type="table-fn">c</xref></td><td align="center" valign="top" rowspan="1" colspan="1">3 (27%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Personal responsibility</td><td align="center" valign="top" rowspan="1" colspan="1">16 (33%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (36%)</td><td align="center" valign="top" rowspan="1" colspan="1">11 (32%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (20%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (46%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (27%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Depression and anxiety</td><td align="center" valign="top" rowspan="1" colspan="1">15 (31%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (50%)<xref rid="TFN13" ref-type="table-fn">b</xref>,<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">8 (24%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (30%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1 (8%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">4 (36%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Risk Screening<sup>1</sup></td><td align="center" valign="top" rowspan="1" colspan="1">12 (25%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (36%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">7 (21%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (9%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Medication adherence</td><td align="center" valign="top" rowspan="1" colspan="1">10 (21%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (36%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (15%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">3 (23%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (9%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Normative influence<xref rid="TFN26" ref-type="table-fn">&#x020ac;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">9 (19%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (29%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5 (15%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (20%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)<xref rid="TFN15" ref-type="table-fn">d</xref></td><td align="center" valign="top" rowspan="1" colspan="1">3 (27%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Intimate partner violence</td><td align="center" valign="top" rowspan="1" colspan="1">4 (8%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (7%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (15%)</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Intervention Intensity</bold></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;1&#x02013;2 sessions</td><td align="center" valign="top" rowspan="1" colspan="1">6 (13%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (14%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (12%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (15%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (9%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;3&#x02013;10 sessions</td><td align="center" valign="top" rowspan="1" colspan="1">30 (63%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (57%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">22 (65%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (80%)<xref rid="TFN13" ref-type="table-fn">b</xref></td><td align="center" valign="top" rowspan="1" colspan="1">6 (46%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (73%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x0003e;10 sessions</td><td align="center" valign="top" rowspan="1" colspan="1">12 (25%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (29%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (24%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td colspan="7" align="left" valign="top" rowspan="1"><bold>Intervention Time Span</bold></td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;1&#x02013;3 months</td><td align="center" valign="top" rowspan="1" colspan="1">33 (69%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (50%)<xref rid="TFN12" ref-type="table-fn">a</xref></td><td align="center" valign="top" rowspan="1" colspan="1">26 (76%)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (90%)<xref rid="TFN12" ref-type="table-fn">a</xref></td><td align="center" valign="top" rowspan="1" colspan="1">8 (62%)</td><td align="center" valign="top" rowspan="1" colspan="1">9 (82%)</td></tr><tr><td colspan="7" align="left" valign="bottom" rowspan="1">
<hr/></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x0003e; 3 months</td><td align="center" valign="top" rowspan="1" colspan="1">15 (31%)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (50%)</td><td align="center" valign="top" rowspan="1" colspan="1">8 (24%)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (10%)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (38%)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (18%)</td></tr></tbody></table><table-wrap-foot><fn id="TFN7"><p>k = the number of interventions</p></fn><fn id="TFN8"><p>EBI = evidence-based interventions that show at least one significant positive intervention effect and have low risk of bias in study design, implementation and analysis</p></fn><fn id="TFN9"><p>Rigorous Non-EBI = interventions show no significant positive intervention effects but have low risk of bias in study design, implementation and analysis</p></fn><fn id="TFN10"><p>Positive non-EBI = interventions show at least one significant positive intervention effect but have high risk of bias in study design, implementation and analysis</p></fn><fn id="TFN11"><p>Other non-EBI = interventions show no significant positive intervention effect and have high risk of bias in study design, implementation and analysis</p></fn><fn id="TFN12"><label>a</label><p>Significant Fisher&#x02019;s Exact test between EBIs and Rigorous non-EBIs (p&#x0003c;0.05)</p></fn><fn id="TFN13"><label>b</label><p>The difference between EBIs and Rigorous non-EBIs, p value approached 0.10 or the percentage differences were 20% or more</p></fn><fn id="TFN14"><label>c</label><p>Significant Fisher&#x02019;s Exact test between EBIs and Positive non-EBIs (p&#x0003c;0.05)</p></fn><fn id="TFN15"><label>d</label><p>The difference between EBIs and Positive non-EBIs, p value approached 0.10 or the percentage differences were 20% or more</p></fn><fn id="TFN16"><label>&#x003b1;</label><p>Not mutually exclusive</p></fn><fn id="TFN17"><label>&#x02020;</label><p>Engaged in unprotected sex with HIV-negative or serostatus unknown sex partners</p></fn><fn id="TFN18"><label>&#x003d5;</label><p>Defined as a study group that receives a non-HIV intervention (e.g. general health promotion) that matched the length and doses of HIV intervention</p></fn><fn id="TFN19"><label>&#x0023a;</label><p>Defined as a study group in which participants are aware of the goals of the intervention (e.g. to reduce sexual or drug use risk)</p></fn><fn id="TFN20"><label>&#x003b2;</label><p>Includes HIV outpatient clinics, community health centers, hospitals, and methadone treatment clinics</p></fn><fn id="TFN21"><label>&#x02260;</label><p>Includes community-based organization, HIV/AIDS service organizations, community storefront, and drop-in center</p></fn><fn id="TFN22"><label>^</label><p>Includes general public area (e.g., park), street location, and community gathering place</p></fn><fn id="TFN23"><label>+</label><p>Includes adult book/video store, bar, and health club</p></fn><fn id="TFN24"><label>&#x000b1;</label><p>Includes counselor, health educator and health care provider</p></fn><fn id="TFN25"><label>&#x000f7;</label><p>Discussing methods to prevent HIV transmission such as abstinence, condom use, not sharing used needles</p></fn><fn id="TFN26"><label>&#x020ac;</label><p>Direct or explicit attempts to change peer norms or participants&#x02019; perceptions of norms</p></fn><fn id="TFN27"><label>&#x000b6;</label><p>Some studies did not report the information</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" position="float" orientation="landscape"><label>Table 3</label><caption><p>Summary of Outcome Measures and Findings by Groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="middle" align="left" rowspan="1" colspan="1">Outcomes and Findings<xref rid="TFN29" ref-type="table-fn">1</xref></th><th valign="middle" align="center" rowspan="1" colspan="1">Total (48 studies)</th><th valign="middle" align="center" rowspan="1" colspan="1">EBIs (14 studies)</th><th valign="middle" align="center" rowspan="1" colspan="1">Rigorous Non-EBIs (10 studies)</th><th valign="middle" align="center" rowspan="1" colspan="1">Positive Non-EBIs (13 studies)</th><th valign="middle" align="center" rowspan="1" colspan="1">Other Non-EBIs (11 studies)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Transmission Risk Behavior (i.e., unprotected sex with HIV-negative or serostatus unknown partners)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic># of studies reported the outcome</italic></td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic># of studies showed significant positive intervention effects</italic></td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Unprotected Sex Behavior (partner serostaturs not reported)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic># of studies reported the outcome</italic></td><td align="center" valign="top" rowspan="1" colspan="1">33</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic># of studies showed significant positive intervention effects</italic></td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Sex and Drug Combined Index</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic># of studies reported the outcome</italic></td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic># of studies showed significant positive intervention effects</italic></td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Injection Drug Use or Needle Sharing</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic># of studies reported the outcome</italic></td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic># of studies showed significant positive intervention effects</italic></td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td colspan="6" align="left" valign="top" rowspan="1">Biologic Outcome (i.e., Sexually Transmitted Diseases)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic># of studies reported the outcome</italic></td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;<italic># of studies showed significant positive intervention effects</italic></td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr></tbody></table><table-wrap-foot><fn id="TFN28"><p>EBI = evidence-based interventions that show at least one significant positive intervention effect and have low risk of bias in study design, implementation and analysis Rigorous Non-EBI = interventions show no significant positive intervention effects but have low risk of bias in study design, implementation and analysis Positive non-EBI = interventions show at least one significant positive intervention effect but have high risk of bias in study design, implementation and analysis Other non-EBI = interventions show no significant positive intervention effect and have high risk of bias in study design, implementation and analysis</p></fn><fn id="TFN29"><label>1</label><p>A study may contribute to more than one outcome measure</p></fn></table-wrap-foot></table-wrap></floats-group></article>